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Abstract
The development of Web 2.0 techniques has led to the prosperity of online communities, which
spread to various domains and areas in our daily life. When it comes to the medicine and
healthcare domain, a series of good online services such as Yahoo! Groups, WebMD and Med-
Help, offer patients and physicians a good platform to discuss health problems, e.g., diseases
and drugs, diagnoses and treatments, which also provide a large volume of data for researchers
to analyze and explore. However, some nature of the personal messages, e.g., unclean, unstruc-
tured and isolated from clinical practice, hinders users’ effective digestion of information in the
front end and challenges the data analysis in the back end. In such a scenario, the objective
of my thesis is to apply the advanced data mining, information retrieval and natural language
processing techniques to effectively analyze and re-organize the rich source of personal health
messages from online medical communities, in order to satisfy patients’ information need and
support physicians’ clinical practice.
Specially, in the first part of the dissertation, I introduce an SVM-based multi-class clas-
sification method which utilizes term-appearance, lexical and semantic features to effectively
classify health messages sampled from our unique dataset of Yahoo! Health Groups into three
categories: News, User Comments and Spam; in the second part, I depict a comprehensive
system with an extensive evaluation framework to organize and cluster patient outcomes utiliz-
ing topic model, which groups large collections of personal comments into a series of topics,
guided by expert comments; in the third part of the dissertation, I address a novel and promis-
ing topic: Comparative Effectiveness Research (CER) hypothesis prediction, by presenting a
ii
study which evaluates patients’ opinions on different treatments by machine enabled sentiment
analysis or human analysts utilizing our MedHelp dataset. By suggesting three different meth-
ods to compare such opinions, reliable conclusions about the patients’ preference on different
treatments can be drawn consistently, which imply the effectiveness of the treatments. Further-
more, the study is also extended to demographic analysis to explore the preference in specific
group of people, representing population cohorts.
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CHAPTER 1
Introduction
The development of Web 2.0 techniques has led to the prosperity of online communities, which
spread to various domains and areas in our daily life. When a person plans to buy an electronic
product, she would like to view other customers’ reviews from shopping websites. When a
user tries to trade on some specific stock, she would like to know other traders’ comments
from online stock discussion board. Web forums in specific area provide valuable information
in support of users’ product judgment by exposing them to others’ recent experiences. Though
subjective, they reflect the most direct and comprehensive opinions from actual people using
actual products.
When it comes to the medicine and healthcare domain, the situation is similar: online
bulletin boards and chat groups, such as Yahoo! Groups1, WebMD2 and MedHelp3. offer
patients and physicians a good platform to discuss health problems, e.g., diseases and drugs,
diagnoses and treatments. These online user discussions also provide rich material for case
studies, which are a standard approach to medicine. From case studies of drug outcomes,
physicians could know how well a drug works, what its outcomes are, including side effects,
and patients could know the experience from similar patients, whether the drug is effective,
under what conditions.
However, online medical discussions have limitations hindering users’ effective digestion
of information – they usually contain millions of unstructured messages. They do offer a
1http://groups.yahoo.com/
2http://www.webmd.com/
3http://www.medhelp.org/
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convenient platform for communication about medical issues while is though lack of direct
connection with clinical practise and evaluation. In addition, various of online medical discus-
sions are addressed by different groups of people thus the topics discussed are diverse. Thus, it
is appealing to effectively analyze and re-organize the rich source of personal health messages
by applying advanced data mining, information retrieval and natural language processing tech-
niques, in order to satisfy patients’ information need and support physicians’ clinical practise.
Many interesting and promising problems are related to the topic of personal health mes-
sage analysis, and re-organization. For our observation, each potential problem consists of
Problem
Technique
Data
Object
Figure 1.1: Three dimensional elements of problems
three dimensional elements: da-
ta sources, objects and techniques,
which is shown in Figure 1.1.
Data sources: Many online ser-
vices offer specific healthcare fo-
rums and discussion boards. For
example: patientslikeme 4, Med-
Help5, Yahoo! Groups in Health
and Wellness, Yahoo! Answers 6 in
Health Category, while people can
freely discuss and post healthcare-
related messages on social network
communities such as Twitter 7 or
Sina weibo 8. Both of the sources
4http://www.patientslikeme.com/
5http://www.medhelp.org/
6http://answers.yahoo.com/
7https://twitter.com/
8http://www.weibo.com/
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can be retrieved and applied in format of text messages. Also, personal health messages also
include voice messages.
Objects: Sometimes users such as patients and pharmacists focus on drugs: what is the
main purpose of each specific drug? Does it have severe side effects? While users’ topics are
also organized by diseases in many forums. People may share the treatment information, or
just experiences about the same disease they may suffer. Furthermore, the messages can also
be organized by treatments, clinical trials, diagnoses or even symptoms.
Techniques: Many applicable techniques in data mining, information retrieval and natural
language processing make it possible to build bridges between conceptual model in computer
science to real medical problems. Such techniques vary according to different problems and
purposes.
Online personal health messages are not always clean: not all messages are relevant and
useful for our learning tasks, i.e., a huge amount of advertisements can be found on the web
forum. Even they are, they may contribute in different ways: some are expertise; some are
comments from patients, etc. If a user searches for a specific drug, there are usually thousands
of comments or reviews returned. The user has difficulty in digesting and understanding the
information quickly – she has to select the useful posts from the pool and filter out the spam. In
such a scenario, it is appealing to classify these messages, not only for the reason of improving
the effectiveness (e.g., filter out spam) but also to benefit the efficiency (e.g., decrease the
number of message to process).
After successfully classifying the messages and acquiring the useful ones, another and even
more challenging problem arises: how to help users to understand and digest such unstructured
messages? In online medical forum, each comment talks about several topics in one piece of
plain text. These messages must be partitioned into parts, and these parts must be grouped
together according to what topic category they each belong to. By doing this we will have a
coherent view on different aspects of the medical issue based on all the information available
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from our source. Our purpose is to integrate and cluster the drug-based outcomes from a
large number of unstructured online messages, into meaningful groups according to the topics,
in order to aid users navigate through the vast information pool and satisfy their information
need.
For the purpose of clinical practice, recently Comparative Effectiveness Research(CER),
which is defined and sponsored by Institute of Medicine [1], draws researchers’ attention to
analyze and compare different interventions and strategies in clinical trials. After successfully
integrating the patients’ outcomes, CER can be conducted to compare the effectiveness of
different drugs or treatments on some specific disease. From the result we can answer the
question: which treatment is more effective and favored by more patients? (e.g., Aspirin is
more effective than Ibuprofen to treat migraine headache). Based on CER’s definition, the real
pragmatic trials are required thus conclusions can not be made by only analyzing text-based
personal messages. However, the comparative results generated from personal messages can
either become the proof of existing CER results, or the hypothesis of future CER topics.
Let us re-consider the three dimensional elements of problems. Figure 1.2 shows the details
of decomposition of the above three problems we proposed. From Figure 1.2 we observe that
various of data sources can be covered, multiple medical objects can be addressed and plenty
of techniques can be explored and applied by solving the proposed problems, which ensures
that the topic is adequately studied. However, for the time and technique limits, some of the
components will not be addressed, e.g., the process of voice health messages, the extraction of
symptoms and diagnoses, etc, which leaves the topic as an open pool for future exploration.
Organization: In the first part of the dissertation, I will introduce an SVM-based multi-
class classification method which utilizes term-appearance, lexical and semantic features to
effectively classify health messages sampled from our unique dataset of Yahoo! Health Groups
into three categories: News, User Comments and Spam.
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Problem
Technique
Data
Object
Yahoo! Groups(P1,P2)
PubMed Health(P2)
MedHelp(P3)
Twitter, Voice Messages
……
Whole text(P1)
Drug(P2)
Disease(P3)
Treatment(P3)
Symptom, diagnoses …
Classification(P1)
Topic model(P2)
Clustering(P2)
Sentiment Analysis(P2,P3)
Statistical Testing(P3)
Social Network Analysis
Time-series Analysis
…
P1: Personal message Classification
P2: Patient Drug Outcomes Integration
P3: CER hypothesis prediction
……
Figure 1.2: Dimension decomposition of three problems
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In the second part of the dissertation, I will present a comprehensive system to organize
and cluster patient outcomes utilizing topic model, which groups large collections of personal
comments into a series of topics, guided by expert comments. A prototype implementation
is built to extract situational evidences by digesting user comments provided by patients. Ten
drugs, belonging to two groups (specialized and generalized) have been sampled and tested
from the same dataset of Yahoo! Health Groups. Also an extensive evaluation of the clustering
results has been performed by medical school students, to validate the good performance of the
system.
In the third part, I will address a novel and promising topic: comparative effectiveness re-
search (CER) hypothesis prediction. Different from the traditional analysis from EMR data set,
we present a study which evaluates patients’ opinions on different treatments by machine en-
abled sentiment analysis or human analysts. By suggesting three different methods to compare
such opinions, we can draw the reliable conclusion about the patients’ preference on different
treatments consistently, which can also imply the effectiveness of the treatments. Furthermore,
the study is also extended to demographic analysis to explore the preference in specific group
of people. As a case study, we utilize MedHelp dataset and focus on two common diseases:
breast cancer and depression to compare the effectiveness of their treatments, respectively.
The conclusions and summaries are given in the last chapter.
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CHAPTER 2
Related Work
Nowadays, many applications utilize formal medical literatures to extract and integrate useful
information. Such applications include: generating text summaries [2], topic modeling [3],
mining predictive rules [4], search query optimization [5], mining drug-AE(adverse effects)
associations [6], evaluation by propensity-score matching [7, 8], and BeeSpace Navigator 1
which builds an interactive system for functional analysis of biological literatures [9, 10, 11].
etc. Compared with the formal literatures, informal medical messages which are generated by
large number of online users are more unstructured and noisy, which challenges the information
extraction.
Instead of formal and structured literatures, some research papers apply natural language
processing techniques on unstructured clinical notes, such as document clustering [12], med-
ication information extraction [13, 14], term characteristics analysis [15], abbreviation anal-
ysis [16], social-history information detection [17], patient identification [18] etc. Compared
with these, personal medical messages are more informal and contain more useless informa-
tion, which challenges the data processing. Meanwhile, the topic diversity of the online per-
sonal messages reflects various responses and opinions from real physicians and patients.
There have been only a few studies using informal medical sources: Crain et al. [19] and
Zhang [20] worked on consumer medical search by using Yahoo! Answer health messages,
while Yang et al. did a solid query log analysis [21] based on the Electronic Medical Record
Search Engine (EMERSE) [22]. Chee et al. have published several papers based on Yahoo!
1http://www.beespace.illinois.edu/
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Groups messages, such as tracking users’ sentiments [23] and prediction of adverse drugs [24].
Using the same dataset, we perform a comprehensive information extraction task and apply a
series of text mining techniques.
Classification in short text messages has been addressed by some researchers. Hidalgo et
al. [25] and Cormack et al. [26] detected spammessages from the data pool while different clas-
sification approaches were applied such as Naive Bayes, SVM, decision trees, etc. Munro [27]
utilized the sub-word variation to classify medical clinic notes written in Chichewa language.
Volkova et al. [28] tried to classify the sentences extracted from animal-disease-related text
into “suspected” or “confirmed” group. Compared with such classification work, the problem
we proposed addresses how to select the feature space which can recognize the characters of
different web medical messages, as well as solving a multi-class classification problem rather
than binary classification.
Topic models such as Probabilistic Latent Semantic Analysis (PLSA) [29] and Laten-
t Dirichlet Allocation (LDA) [30] have been applied to text mining problems [31, 32, 33,
34, 35, 36] with good results. For example, Lu et al. applied PLSA model to integrate product
aspects [37] and assign rating [38] from online product reviews, while Kandulaweb et al. [39]
utilized LDA model to discover diabetic-related medical materials. In the above work, limited
evaluations upon a small number of manual post-labeling were applied. Undertaking semi-
supervised PLSA model, a convincing evaluation strategy based on a large-scale gold standard
data produced by professionals is effective to evaluate the performance of the model.
Comparative Effectiveness Research (CER) identifies what treatment works best for which
patients under what circumstances. The conclusions can aid consumer, patients, and care
providers’ decisions on which diagnostic or treatment option to use. Lately, a number of s-
tudies have taken the initiatives to operationalize the concept of CER in medical research
( [40, 41, 42]). For example, Sox and Greenfield [43] introduced the CER definition, high-
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priority topics, methodologies of CER as well as the translation from research findings to the
patient care, which give a comprehensive guide for the further CER.
Some studies aims at outlining the general framework of CER research. For example, Rat-
ner et al [44] as IOM committee chairs reported the priority directions of CER field and Luce
et al [45] discussed the better research methods on CER. Trill [46] , Garber and Tunis [47] dis-
cussed the relation between CER and personalized medicine. Meanwhile increasing number
of research papers published have explored CER for specific condition. For example, CER in
chronic obstructive pulmonary disease(COPD) [48], asthma [49], Raiology [50] [51], colorec-
tal cancer [52], heart disease(IHD) [53], etc.
Comparative Effectiveness Research (CER) also increasingly draws researchers’ attention
in medical informatics area [54]. Djulbegovic [55] discussed the importance of applying data
mining techniques in CER. Bhavnani et al. analyzed the clinic trail network on depression [56]
and the relation with CER. Roy and Hennesy applied Bayesian model to compare the effective-
ness among the drug classes on hypertension [57], etc. However, to the best of our knowledge,
few studies have explored how to detect the treatment effectiveness by mining personal mes-
sages, which could be a highly promising area for informing clinical trial and other formal
CER methods.
Comparative study has been a frequently visited topic by researchers in text mining area.
Jindal and Liu did solid research work on detecting the comparative sentences and relations
from text documents [58], [59], as well as the sentiment analysis in text [60], [61]. Based
on such fundamental work, some researchers did comparative study by analyzing the online
product reviews, such as product comparison and recommendation [62], [63], opinion visu-
alization [64], generating comparative summaries [65], judgement aggregation [66], etc. My
dissertation utilizes some of the techniques in the above paper and apply them on the personal
health messages.
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CHAPTER 3
Multi-class Classification in Online
Personal Health Messages
In this section, I propose an effective approach to process and digest the raw data about health-
care – to classify all the messages into three main categories: News (N), User comment (C) and
Spam (S). Based on such results, different analysis can be applied on specific category data in
purpose.
Particularly, an SVM-based multi-class classification method is applied to separate the mes-
sages into three pre-defined categories. The core step of SVM classification is to select the
proper feature spaces. We carefully choose three kinds of feature spaces: term appearance,
lexical and semantic feature. Based on that, a tri-class SVM classifier has been trained upon
the health messages sampled from our unique dataset of Yahoo! Groups under Health and
Wellness.
We apply 10-fold cross-validation to verify the quality of the classifier and design several
experiments to choose the best combination of the feature spaces. Evaluation results show that
our classifier can achieve a high accuracy (90:15%) while all three kinds of features are applied.
Our SVM-based multi-class classification approach with careful feature-space selection can
successfully classify the health messages into different categories, especially the most useful
part – user comments.
The section of work is complete and published in Proceeding of 2011 International work-
shop on Web Science and Information Exchange in the Medical Web (MedEX 2011), co-
located with 2011 International Conference on Information and KnowledgeManagement (CIK-
M 2011) [67].
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Organization. Section 3.1 defines the problem, as the solution of which an SVM-based
multi-class classifier is proposed in Section 3.2. We then present experiments and results on
Yahoo! Groups data in Section 3.3. Finally, we make conclusion in Section 3.4.
11
3.1 Problem Definition
According to the observation on our unique dataset from Yahoo! Groups, containing 12M
personal messages from 27K public groups in Health and Wellness, we can specify all the
messages into three categories:
 News (N): Community members may quote some news articles in their posts, whose
content is about the latest scientific discovery or FDA announcement of medical drug or
treatment. Such messages are usually very long, having several paragraphs, and written
by scientific journalists. This kind of messages can be used to extract medical entities,
event and expert opinions [68] or to compare the language usage with other sources [69].
 Comment (C): User comments reflect direct opinions from actual patients and physicians
on specific healthcare topics. They have proper lengths and most of the parts are infor-
mational. In Chee’s work using the same dataset [70], this kind of messages was actually
applied to evaluate the sentiment of user opinions. Also an opinion integration system
could be built upon such messages.
 Spam (S): Most advertisements [71], posted by human or robots, should be eliminated
for our purpose. They are often short, and appear repeatedly, which makes it easy to
identify them automatically.
Table 3.1 shows a snippet of each category of messages, which are extracted from the real
Yahoo data.
To automatically detect each message’s category, we propose an SVM-based multi-class
classification method. To train an accurate classifier where the core step is feature selection, we
carefully select three kinds of feature spaces, namely term-appearance, lexical and semantic
feature. Based on the feature space, we translate and label the health messages sampled from
12
...An FDA drug advisory panel deliberat-
ing about the safety of Sanofi-Aventis’ mar-
keting application for its weight reducing
drug, Zimulti rejected the application 14 to
0. They did so on the basis of the evidence
presented.
The panel was informed by an medical re-
viewer, Dr. Amy G. Egan, that: ”The po-
tential market for this drug and the contin-
ued uncertainty about its risks, both known
and unknown, lead to our concern about the
use of this drug in the general population. ...
(a). News (N)
...I am on Meridia. I started taking it six
days ago continuously now. I had tried it a
month or so ago, and got worried and anx-
ious about the side effects, so I stopped tak-
ing it after 3 days, but now I am glad that I
restarted it.
I am 5’6” @ 36 years old, (almost 37) and s-
tarted out at 263 pounds. I am a binge eater.
I used to skip breakfast and then binge the
rest of the day. I was not exercising or eat-
ing for health. My LDL’s were sky high,
and my HDL were low. I have high choles-
terol etc. However, I have NORMAL blood
pressure and resting pulse, which is impor-
tant in starting Meridia (sibutrimine) ...
(b). User comment (C)
...
Everything is 70% off for this week only!
Get for men’s health
Buy Valium for CHEAP
Get Xanax for Anti-Anxiety.
Buy Meridia online for weight loss
Get Ambien to help you sleep
We have all the products for your needs:
Angina, Arthritis, Antibiotic, Anxiety disorder
...
(c). Spam (S)
Table 3.1: Message Examples
our unique dataset of Yahoo! Groups with Health and Wellness and train a tri-class SVM
classifier with a RBF kernel upon it. In Section 3.2, we will introduce the method in details.
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3.2 Methodology
We apply SVM classification [72] to classify all the messages into three classes (N, C, S).
Support vector machines (SVM) are a group of related supervised learning methods which are
used for classification task analyzing data and recognizing patterns. More paretically, a support
vector machine builds a hyper-plane or multiple hyper-planes (when there are multiple classes)
in a relatively high-dimensional space, in order to make the distance from hyper-planes to the
nearest training data as far as possible, to minimize the error. Compared with other potential
approaches like manually labeling, rule-based parsing, SVM has relatively high accuracy and
can handle high-dimensional data automatically. The main steps are as follows:
 Choose the data pool and label messages in the pool as news (N), user comment (C), and
spam (S).
 Select the proper feature spaces and transfer each message into a vector, where each
dimension refers to one feature.
 Separate the pool into training and testing set. Train an SVM classifier on the training
set, which automatically studies the weight of each dimension and find the most discrim-
inative margin.
 Test the classifier on the testing set.
The most essential step is the feature selection. Our approach explores three kinds of feature
spaces: term appearance, lexical and semantic feature.
Term-appearance feature (TA): Some text classification work [24, 73] has already ex-
plored such feature as term frequency (TF): for each message i’s feature vector v(i), the value
of dimension j: v(i; j) refers to the number of appearances of the term j in message i. In the
paper we use one additional representative format – word distribution (WD) which represents
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the probability of term’s appearance in a message. i.e.,
v(i; j) =   freq(i; j)
length(i)
+ (1  )  p(j; B) (3.1)
In Formula, freq(i; j) refers to the frequency of term j in message i, length(i)means the total
number of terms in message i, and p(j; B) shows the probability of term j in the whole text
collectionB. Actually word distribution (WD) is a normalized version of term frequency (TF).
We will test which one suits our classifier better in Section 3.3.
Should all the terms or only high-TA terms be included in the feature space? Intuitively,
many terms with low TA may involve noises since their appearances are randomly scattered
across multiple messages if all the terms are included. However insufficient feature size may
miss some discriminative terms if only a few high-TA terms are considered. Both cases would
damage the accuracy. Thus we will discuss the range of term choosing in the experiment.
Lexical feature (LE): This feature space includes a series of lexical statistics of one mes-
sage, from which we know the structural information e.g., terms, sentences, paragraphs, even
punctuation. From Instruction Section we have the sense that lexical features may be discrim-
inative among three types of messages. Applying lexical feature would distinguish them well.
Here we list several lexical features:
 The number of terms/unique terms
 The ratio of unique terms to total number of terms
 The number of sentences/paragraphs
 The average length of sentences/paragraphs
 The number/percentage of uppercase terms
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Semantic feature (SE): These features analyze the semantic meaning of one message,
which need to “understand” the content, including:
 The number/percentage of drug/treatment names
 The number/percentage of medical terms
 The number/percentage of sentences with medical terms
 The number/percentage of paragraphs with medical terms
 The percentage of positive/negative/subjective sentences
Since different types of messages always express different content by purpose, semantic
features would be potentially good discriminators although capturing them is more challenging
than lexical features. We generate drug/treatment names from a professional drug website 1 as
well as medical terms from wikipedia 2, and extract them from each message. For sentiment
analysis, we utilize a sentiment analysis tool [60] which is capable of determining the sentiment
polarity of each sentence, i.e., positive or negative opinions. We train a tri-class SVM classifier
and design a series of experiments to select the proper feature spaces and test the performance
in Section 3.3.
1http://www.drugs.com/
2http://en.wikipedia.org/
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3.3 Experiment and Result
3.3.1 Data and Setup
We utilize our unique dataset which is segmented from Yahoo! Groups with Health and Well-
ness data to build the SVM classifier and test. The dataset consists of 27; 290 public groups
and 12; 519; 807 messages in total, crossing seven years and covering various topics. The data
has been applied in Chee’s work [70, 24]. All the experiments run on a 4TB-disk, 4GB-RAM,
and 10-core server.
We randomly choose 1254messages from the mixed collection as our data pool. After man-
ually labeling them we acquire 293 pieces of news (N), 329 user comments (C) as well as 632
pieces of spam (S). Since our data comes from public groups which are open to all web users,
spam (S) takes a much larger portion than that in private groups where only registered group
members can communicate with each other in order to prevent other individuals or robots from
sending advertisements and irrelevant messages. From this we can see the personal messages
are really dirty – a huge number of data is useless and should be eliminated.
We then apply 10-fold cross-validation [74] to verify the quality of the classifier. The
labeled data is randomly partitioned into 10 equal-sized subsets. Each time one single set is
selected as testing set for evaluation and the rest 9 subsets are used as training set. The whole
process will be repeated 10 times to make sure each subset be tested exact once. We use
accuracy as the evaluation metric, defined as:
Accuracy = # correctly classified messages=# of tested sentences (3.2)
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3.3.2 Experiment 1: Choosing Proper Term-appearance (TA) Feature
As we discussed in Method Section, Word distribution (WD) and Term frequency (TF) are
two formats of Term appearance (TA) feature. We would choose one of them which shows
higher performance. Meanwhile, we also need to determine the range of terms choosing in the
experiment.
We rank all the terms appearing in the data pool according to TF, choose the terms ap-
pearing at least k times and calculate TF and WD of selected terms to form the feature space,
respectively. Apparently, a larger k refers to a smaller number of terms chosen.
k Feature Space Size (# of terms chosen) Accuracy (TF) Accuracy (WD)
3 6211 78.29% 80.71%
10 2846 78.03% 80.03%
20 1878 80.59% 83.11%
50 927 80.08% 82.79%
100 507 79.13% 82.54%
200 248 77.29% 81.46%
500 93 75.38% 78.57%
k means the terms which appear at least k times in the pool
Table 3.2: The Result of Term-appearance feature
Table 3.2 shows the evaluation results of different choices of TA feature spaces. We observe
that generally the classifiers using word distribution (WD) outperform than ones using term
frequency (TF). This is reasonable since Word distribution (WD) is the normalized version of
Term frequency (TF) by the text length and WD even considers tuning the influence of stop
words. Thus WD describes the text form more precisely.
When it comes to the range of terms chosen, as we expected, over-sized or under-sized
feature space hurts the performance. Finally the Term-appearance (TA) feature space will
reach the best performance when Word distribution (WD) is applied and terms appearing at
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least 20 times (k=20) are chosen. This will become the standard of TA feature setting in the
following experiments.
3.3.3 Experiment 2: Choosing Proper Combination of Feature Spaces
In this section, we explore three kinds of features: spaces: Term appearance (TA), lexical
(LE) and semantic (SE) feature. How to utilize such features? Solely or combinedly? In
this experiment we test the performance of classifiers using each kind of feature respectively,
and different combinations among them. The results are still present by accuracy and compared
with the baseline which utilizes Term appearance (TA) solely. Table 3.3 shows the performance
of each possible feature selection:
Feature space Feature Space Size Accuracy Change
Term appearance (TA) 1878 83.11% /
Lexical (LE) 14 84% +1.07%
Semantic (SE) 21 78.60% -5.43%
TA + LE 1892 85.20% +2.51%
TA + SE 1899 86.46% +4.03%
LE + SE 35 87.86% +5.71%
TA + LE + SE 1913 90.15% +8.47%
Table 3.3: The Result of different feature selection
From the result we observed the following facts:
 Lexical (LE) and semantic (SE) feature can fairly capture the differences among the
messages, i.e., to distinguish each kind of message from other, even with a much smaller
feature space size.
 To utilize the combination of feature space will improve the performance of using them
solely. Using two features improve the baseline by 2:51% (TA + LE), 4:03% (TA + SE),
and 5:71% (LE + SE), respectively.
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 The whole combination of three kinds of features overwhelms any other selection. The
accuracy reaches 90.15%, which improves the baseline a lot (8.47%).
3.3.4 Experiment 3: The Performance of Detecting User Comments (C)
Compared with News (N) which is difficult to parse, Spam (S) which is almost useless, User
comment (C) reflects the most opinions from actual patients and doctors. Thus, user comments
would become our target message category to be directly applied in the future. In this exper-
iment, we will repeat what we did in Section 3.3.4 instead of changing the evaluation metrics
to precision, recall, and F-score of user comments (C), defined as:
Precision = # of messages correctly classified as C=# of user comments C (3.3)
Recall = # of messages correctly classified as C=# of messages classified as C (3.4)
F-score = 2  Precision  Recall=(Precision+ Recall) (3.5)
Feature space Feature Space Size Recall of C Precision of C F-score
Term appearance (TA) 1878 85.10% 84.75% 84.92%
Lexical (LE) 14 85.71% 86.05% 85.88%
Semantic (SE) 21 82.07% 82.85% 82.46%
TA + LE 1892 87.74% 86.98% 87.36%
TA + SE 1899 87.53% 87.75% 87.64%
LE + SE 35 90.58% 90.08% 90.33%
TA + LE + SE 1913 93.31% 93.92% 93.61%
Table 3.4: The Result of detecting user comments C
From Table 3.4 we will not only make the same observation as Section 3.3.4: the whole
combination acquires best performance, but also notice that our feature selection can detect
user comment (C) more precisely since the recall value (actually it is the accuracy of detecting
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user C) is higher than the overall accuracy in every case. The best performance to detect user
comment C is 93.61% by F-score while three feature spaces are fully combined. This fact
makes sense since user comments (C) are more consistent with the feature spaces while news
(N) and spam(S) are more diverse.
The high accuracy of our classifier ensures the quantity of the personal messages to be
processed in our following problem: drug outcome integration, which will be discussed in
Section 4.
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3.4 Conclusion
In this chapter, I propose a multi-class SVM-based classification method by proper feature
selection upon web personal healthcare messages where term-appearance, lexical and seman-
tic features are applied. Experiments show that our approach could successfully distinguish
healthcare messages in medicine forum as news, user comments, and spams, which (90:15%)
outperforms the baseline case by 8:47% in accuracy. Future work includes improvement of the
accuracy of the current result as well as further utilization of recognized news and comment
messages.
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CHAPTER 4
Designing and Evaluating a Clustering
System for Integrating Patient Drug
Outcomes
In this section, I propose a comprehensive system to organize and integrate patient outcomes
utilizing semantic analysis, which groups large collections of personal comments into a series
of topics. A prototype implementation was built to extract situational evidences by filtering and
digesting user comments provided by patients. Our methods do not require extensive training
or dictionaries, while categorizing comments based on expert opinions from standard source,
or patient-specified categories. This system has been tested with sample health messages from
our unique dataset from Yahoo! Groups, containing 12M personal messages from 27K public
groups in Health and Wellness. We have performed an extensive evaluation of the cluster-
ing results with medical students. Evaluated results show high quality of labeled clustering,
promising an effective automatic system for discovering patient outcomes from large volumes
of health information.
As I introduced in Section 1, unlike product reviews, medical discussion messages are
unstructured, i.e., each comment talks about several topics in one piece of plain text. These
messages must be partitioned into parts, and these parts must be grouped together according
to what topic category they each belong to. By doing this we will have a coherent view on
different aspects of the medical issue based on all the information available from our source.
Our purpose is to re-construct and integrate a large number of unstructured online messages,
into meaningful groups according to the topics, in order to aid users navigate through the vast
information pool and satisfy their information need.
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We designed a prototype model for clustering patient outcomes by effectively digesting
large volumes of personal health messages. First, the useful user comments are retained, while
news and advertisements which are noise for our purpose, are filtered out by an Support Vector
Machine (SVM)-based classifier. In the main step, similar topics are grouped from sentences
appearing in different messages by Probabilistic Latent Semantic Analysis (PLSA) topic mod-
el, where the topic categories can be guided by standard outcome descriptions from expert
sources. In addition to identifying the sentences which are similar to(agree with) expert opin-
ion into the corresponding topic, the model also clusters the sentences which are opposite
to(disagree with) expert opinion into the same topic. In other words, for each outcome provid-
ed by experts, the system automatically identifies the sentences which provide positive support
for the expert opinion and those provide negative support. The process organizes and integrates
all the messages from online medical discussions in a practical way, relevant to particular per-
sons in particular situations.
We have implemented a prototype interactive system for text mining of health messages.
This system has been tested with sample messages from our unique dataset from Yahoo!
Groups, which contains 12M personal messages from 27K public groups in Health and Well-
ness. This outcome research utilizes deeper processing of natural language, such as SVM and
PLSA, than our previous studies on drug reactions with the same dataset [23, 24]. Our methods
do not require extensive training nor dictionaries. In addition, they allow users to specify their
own topics for digesting. Therefore, our methods provide general and powerful solutions to
mine health messages.
We have evaluated the prototype system with a sample set of drugs using a sample cohort
of medical students. 5000 sentences relevant to 10 representative drugs were randomly select-
ed, and automatically clustered into topics extracted from PubMed Health database 1, a well
known expert source for drug information. The accuracy of these clustering results was eval-
1http://www.nlm.nih.gov/pubmedhealth/
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uated by medical students in the College of Medicine at the University of Illinois in Urbana.
By comparing the automatically generated clustering results to the ones generated by these
professional annotators, it is shown that our topic clustering methods produce highly accurate
results. We also statistically prove that all judges were consistent in classifying the sentences
and thus have produced a valid gold standard for our evaluation.
Guided by the standard expert opinions extracted from PubMed Health, our topic cluster-
ing provides robust automatic classification of patient-reported drug outcomes. That is, our
system can automatically classify patient outcomes, which describe patients’ experience and
result of using a particular drug, often using layman language, into standard categories derived
from PubMed Health, with high accuracy. Drugs used for our evaluation can be divided into
two classes: specialized and generalized. The first class treats a particular medical condition
(e.g.,Metformin), while the second class includes over-the-counter drugs (e.g., Ibuprofen) and
commonly-prescribed-drugs (e.g., Heparin). The results show the accuracy of clustering spe-
cialized drugs is higher than that of generalized drugs. This is reasonable since specialized
drugs often have a focused range of treatments and side effects, which makes patients’ out-
come description more specific and consistent. In addition, we also observe that the clustering
methods work better for more common drugs, possibly because users are likely to be more
knowledgeable about drugs they encounter often.
We also show that our system can explore outcomes not included in the standard expert
source. In this particular experiment, we have computed an additional cluster that groups
together sentences not closely associated with any of the standard clusters. By examining
this additional cluster, we discover some patient comments concerning serious side-effects or
other treatments, but not discussed in the standard outcome description on PubMed Health.
By referring to the medical literature, we are able to confirm many of these patient-provided
outcomes have been recorded as possible results of using the particular drug. Patient-reported
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outcomes can be an important supplementary source of information, even when automatically
extracted from health messages.
The section of work is complete and is published in American Medical Informatics As-
sociation Annual Symposium 2012, which is the the worlds premier scientific meeting for
biomedical and health informatics [75].
Organization. Section 4.1 formally describes the problem definition, followed by the ar-
chitecture of the system in Section 4.2. I will introduce the solution of each step in Section 4.3,
including (1). Pre-processing: Filtering the messages, (2). Clustering: Outcome selection
and integration and (3). Post-processing: Separating similar and opposite opinions, and then
present the evaluation setting, experiment and results on Yahoo! Groups data in Section 4.4.
Finally, I will make conclusion and discuss the future work in Section 4.5.
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4.1 Problem Definition
For one particular drug, we collect all the related health messages from Yahoo! Groups, denot-
ed asM , in whichN is the set of all the news, C is the set of all the user comments (our target),
and S is the set of all the spam such as advertisements. Clearly, we haveM = N [ C [ S.
After successfully extracting C, we split it into a set of meaningful sentences, denoted as
D. Each sentence d 2 D is called a comment unit, which would potentially present one side
of outcomes. Our target goal is to group all the comments intommeaningful outcome clusters
O1; O2; :::Om, given the collection D.
Here are several key concepts to be introduced:
 Expert comment ei: To better cluster the outcomes, semi-supervised PLSA model [29]
is applied. Expert comments aim to offer the prior knowledge for PLSA and guide the
topic of each Oi. For each Oi we have one expert comment ei. Compared with the user
comments, the expert comments are more well-written, professional and semantically
vertical to each other. We collect the set of expert commentsE (formed by e1; e2; :::em 1)
for each drug, from the PubMed Health database of U.S. National Library of Medicine2.
The reason why we choosem 1 expert comments is that we want to create some groups
of opinions with prior expert knowledge (O1; O2; :::Om 1) as well as another group of
opinions whose topics are beyond the expert’s (Om).
 Similar opinionOi sim andOpposite opinionOi opp: Each outcomeOi (1  i  m 1)
consists of a group of comment units Di and is associated with one expert comment ei.
Some of the comments represent similar or relevant opinion with ei, which form Oi sim.
Others reflect different or opposite opinions from ei, though they still talk about the same
topic. We call such collection Oi opp.
2http://www.nlm.nih.gov/pubmedhealth/
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Figure 4.1: The architecture of the integration system
4.2 System Architecture
Figure 4.1 illustrates the whole design and implementation process of our system.
Messages from Yahoo! Groups are firstly organized by drug and then classified into three
categories: N , C, S. N and S are eliminated while the the collection of comment units (D)
is extracted from user comments (C), together with the expert comments (E) as input. On the
one hand, such comment units (D) will be re-organized and integrated into several meaningful
outcomes O1; O2; :::Om by our topic model, and presented to audiences via our interactive
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system interface. On the other hand, judges will annotate the extracted data (D and E). Their
annotation results will become a gold standard to evaluate the performance of our model. In
Section 4.3 we will introduce the key components of our system in details.
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4.3 Methodology
As we introduced before, there are several steps to complete the whole task.
 Data Pre-processing (step 1): The input is the whole collectionM . We will separate it
into three categories: News (N ), Comment (N ) and Spam (S). C is our target while N ,
T will be filtered out. C is then split into a set of comment units D.
 Data Clustering (step 2): Given D and m   1 expert comments e1; e2; :::em 1, we will
generate m outcome clusters O1; O2; :::; Om. Each cluster Oi refers to one meaningful
drug outcome, either guided by expert opinion ei (1  i  m   1), or contributing to
“other opinions” (i = m).
 Data Post-processing (step 3): For each cluster with prior expert knowledge Oi, we will
split it into Oi sim – expressing the similar opinion to ei, as well as Oi opp, which shows
the opposite opinion.
4.3.1 Pre-processing: Filtering the Messages
To distinguish the messages M , we applied the multi-class SVM-based classifier we have
trained and implemented in Section 3, The evaluation result shows that we can precisely ac-
quire the user comments (C) for each drug.
4.3.2 Clustering: Outcome Selection and Integration
To achieve our core step of the system: grouping the comments into reasonable and discrim-
inative clusters, where each cluster represent one main outcome of the drug, semi-supervised
PLSA model [29] is applied. We would introduce the model first and then describe the integra-
tion process.
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PLSA model
In PLSA model, we consider each comment unit d 2 D is generated from a mixture of
m + 1 multinomial component models. One component model is the background model B
which dismisses the affect of non-discriminative (i.e., stopwords) words and the rest are m
latent theme topic models (saying  = f1; 2; :::mg), each of which captures one topic. Each
comment unit (i.e. sentence) d can then be regarded as a sample of the following mixture
model:
pd(w) = Bp(wjB) + (1  B)
mX
j=1
[d;jp(wjj)] (4.1)
Here d;j refers to a document-specific mixing weight for the j-th aspect. w is a word. By
applying Expectation Maximization (EM) algorithm [76], a method for finding maximum like-
lihood estimates of parameters in statistical models, all the parameters and results can be com-
puted and updated using the following formulas:
p(zd; w; j) =
(1  B)(n)d;j p(n)(wjj)
Bp(wjB) + (1  B)
Pk
j0=1 
(n)
d;j0p
(n)(wjj0)
(4.2)
p(zd; w;B) =
Bp(wjB)
Bp(wjB) + (1  B)
Pk
j0=1 
(n)
d;j0p
(n)(wjj0)
(4.3)

(n+1)
d;j =
P
w2V c(w; d)p(zd;w;j)P
j0
P
w2V c(w; d)p(zd;w;j0)
(4.4)
p(n+1)(wjj) =
P
d2D c(w; d)p(zd;w;j)P
w02V
P
d2D c(w
0; d)p(zd;w0;j)
(4.5)
To better cluster m outcomes, we can enroll some prior knowledge by extending the basic
PLSA based on expert comments e1; e2; :::; em 1 (i.e., semi-supervised). For each outcome
cluster Oi (1  i  m   1), since we have already acquired the expert comment ei, we
can build a unigram language model fp(wjei)g and incorporate it into the above formulas,
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Formula 4.5 will turn into Formula 4.6 as below:
p(n+1)(wjj) =
P
d2D c(w; d)p(zd;w;j) + p(wjej)P
w02V
P
d02D c(w
0; d0)p(zd0;w0;j) + 
(4.6)
Note, for cluster Om, there is no prior knowledge since we expect to discover some additional
opinions rather than the experts’.
Integration Progress
To build m meaningful clusters by applying semi-supervised PLSA model, there are several
steps described below:
 Build the prior knowledge. For each cluster Oi (1  i  m   1), we have already
acquired an expert comment ei from PubMed Health database of U.S. National Library
of Medicine. Based on it, we estimate fp(wjei)g by Maximum Likelihood as the prior
estimator. Here only adjectives, adverbs, verbs and nouns are considered in the estimator
since they are the terms which express the opinions.
 Given such prior knowledge and the set of the comment units D, we could estimate the
topic models f1; 2; :::mg by the formulas above.
 For each comment unit d 2 D, we assign it to the most suitable cluster by the following
formula:
a
j
rgmax p(djj) = a
j
rgmax
X
w2V
c(w; d)p(wjj) (4.7)
 For each opinion Oi, we generate a topic model j as well as a bunch of corresponding
comment unitsDi. the terms which has high probability p(wjj) in j as well as featured
comment unites can represent such topic.
We apply the above process on the real data and will show the result in Section 4.4.
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4.3.3 Post-processing: Separating Similar and Opposite Opinions
Now in each clusterOi, there are a couple of assigned comment unitsDi. For the cluster which
has a prior expert comment, we will split it into Similar opinion Oi sim and Opposite opinion
Oi opp, by applying semi-supervised PLSA model (creating two clusters with ei as one Oi sim’s
prior knowledge while Oi opp has no prior knowledge).
To create such two clusters, the straightforward approach is to build one cluster’s prior
estimator fp(wjei)g by the typical way: all the adjectives, adverbs, verbs and nouns are con-
sidered in the estimator since they are the terms which express the opinions, and leave another
cluster’s prior as empty.
This approach has one limitation that it does not address the sentiment meaning. Look at the
following two sentences: “I took some Aspirin to treat the back pain and it works well”. “I took
some Aspirin to treat the back pain, but bad effect.” They have nearly the same vocabularies
to address the same topic but with opposite opinions. For such sentences with similar lexical
structure, a better way to distinguish them is to detect the sentiment terms. i.e., “well” and
“bad”, which are key points to express the positive opinion and negative opinion, respectively.
Start with this observation, we propose another approach to build the prior estimator fp(wjei)g
where only positive/negative terms in ei are considered. Since all the sentences in Oi have
already been considered to have the same topic with ei. It is more appropriate to focus on the
sentiments while splitting Oi into Oi sim and Oi opp.
In Section 4.4, we will implement each approach respectively and compare their perfor-
mances.
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4.4 Experiments and Results
4.4.1 Data and Setup
We utilize our unique dataset which is segmented from Yahoo! Groups with Health and Well-
ness data. The dataset consists of 27; 290 public groups and 12; 519; 807 messages in total,
crossing seven years and covering multiple topics. All the experiments run on a 4TB-disk,
4GB-RAM, and 10-core server.
We have trained an SVM-based tri-class classifier with an RBF kernel on the real data and
tested it. Evaluation results [67] show that our classifier can achieve 90:15% overall accuracy as
well as 93.61% by F-score of detecting user comments (C), which indicates that our approach
could successfully distinguish messages’ categories, especially user comments.
Since we are targeting personal medical information, we choose to design the system with
outcomes of specific drugs. From the data pool we select 10 drugs and each appears more than
1000 times. Their relatively high frequency of appearance may ensure that sufficient personal
messages can be processed. Half of the drugs are Prescription - Variety Medical Conditions
(Prescript-VMC) drugs: Metformin, Clonidine, Gabapentin, Clonazepam and Oxaliplatin,
and five are Pain Relief (may be OTC) or Anti-coagulation (PRAC) medications: Aspirin,
Heparin, Ibuprofen, Hydrocodone and Naproxen. For each drug, we collect all the messages
containing it, process them by our classifier and get the user comments C, split C and collect
sentences D which either contain the drug name, or are next to the sentences containing the
drug. These sentences D potentially represent users’ diverse opinions on the drug.
We were aware that a more straightforward approach is to compare Prescription drugs with
out-the-counter (OTC) drugs. However, OTC drugs tend to contain more noisy data and we
noticed that, after pre-processing, many OTC drugs simply do not have enough information
on this forum of proper length and diversity for our evaluation purpose. In this case, we set
two groups as Prescript-VMC drugs with different specific treatments, and PRAC with more
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general treatments, such as some OTC drugs (Aspirin, Naproxen, Ibuprofen) as well as drugs
with similar treatments (Hydrocodone and Heparin).
Due to the uniqueness of our data source – Yahoo! Groups, it is difficult to apply the tradi-
tional evaluation approaches by comparing to a gold standard like TREC medical informatic-
s [77]. Thus, a comprehensive evaluation system which contains a large-scale of professional-
labeled sentences as our gold standard should be built and applied.
4.4.2 Annotation Framework
We have built an interactive web-based database system to support the evaluation process. 500
comment units (i.e., sentences) are randomly generated for each drug and stored in the database
(Note, for some drug like Naproxen, the total number of available comment units is slightly
more than 500). For a specific drug, the professional judge needs to get familiar with the pre-
defined expert comments (8-10 per drug), each of which is associated with a given tag, and then
enter the actual annotation. Each time one comment unit d is given together with its context
in the actual personal message. The judge needs to understand the meaning of d and assign
it to the most suitable cluster (recognized by the tag of the corresponding expert opinion) it
belongs to, or to “other” cluster if no prior expert opinion matches. After that, the judge is also
asked to determine whether d shows similar or opposite opinion with the chosen expert’s. The
annotation of one comment unit is then finished and the result will be stored in the database.
Figure 4.2 simplifies the interface for the annotation process.
Similar to Blake’s work [78], we design a two-step annotation process. The purpose of the
first step, a pilot study, is to validate the design of annotation process, including the instruction
and defined categories, is easy to understand and unambiguous for human annotators. If the
pilot study shows there is no large variance of understanding about the annotation process
among the annotators, we will proceed to the main study to complete the actual annotation.
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(a) Choose the drug
(b) Label a sentence
Figure 4.2: Annotation Interface
Pilot study: In this experiment, three graduate students (majors are computer science, nu-
trition and bioinformatics) and one medical school student were enrolled. We assigned each
of them 100 identical sentences (50 for Prescript-VMC and 50 for PRAC, randomly generated,
covering all common clusters) and they labeled the sentences independently following the in-
structions. Then we collect their annotations and test the inter-rater agreement by using Fleiss’
kappa [79]. Fleiss’ kappa is widely used for assessing the reliability of agreement between a
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fixed number of judges when assigning categorical ratings to a number of items or classifying
items.
From computation, the four judges’ kappa-value reaches 0:84. According to the interpreta-
tion of the kappa statistic [80], this result shows almost-perfect agreement among the judges,
which proves that our annotation process is designed with minimum ambiguousness.
Main study: To reach our initial goal, a gold standard should be made by professional
annotators upon all the sentences. In the main study, we invited 10 medical school students
who are well-trained, experienced, and familiar with information about drugs and treatments
thus qualified as our standard maker. For time and quality concern, it is impossible to ask one
judge to label all the sentences so we randomly split the whole annotation task to 10 judges.
To test the inter-judge reliability, we repeated the process of pilot study – assigning them 50
identical sentences, which are randomly selected from the sentence pool and cover all common
clusters. The Fleiss’ kappa value reaches 0:81, which is considered almost perfect agreement.
The above results indicate that there is no significant variance among all the annotators,
and prove that, by comprehending the task instruction, our judges are well-trained enough to
provide generally consistent gold standard. Therefore, we could confidently apply the gold
standard to evaluate our clustering results. The whole annotation process lasted half a month
and a random follow-up check was executed by two other medical school students afterward.
The output of such well-designed and professional-enrolled annotation framework is good e-
nough to become not only the gold standard of our integrated system, but also a useful resource
for further research.
4.4.3 Clustering Results and Analysis
Now we have the set of comment units D for each drug, as well as the expert comments E
extracted from PubMed Health database of U.S. National Library of Medicine. The number
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of expert comments for each drug is based on the content of the description in the database.
Thus it varies from 8 to 10 for different drugs. According to the semi-supervised PLSA model
introduced before, we assign each comment unit to the suitable cluster with prior expert knowl-
edge or “other outcome” cluster without prior knowledge and compare the results to the gold
standard data.
To measure the quality of our clustering results, we utilize the following measurements:
accuracy, precision, recall and F-score, which are defined by:
Accuracy = # of correctly clustered sentences=# of total sentences (4.8)
Precision = # of correctly clustered expert sentences=# of total expert sentences retrieved
(4.9)
Recall = # of correctly clustered expert sentences=# of total “real” expert sentences (4.10)
F-score = 2  Precision  Recall=(Precision+ Recall) (4.11)
In Formula 4.9 and 4.10, “expert sentence” means the sentence which is assigned into a cluster
associated with one expect opinion (O1; :::Om 1), regardless of annotated or auto-retrieved,
and “real expert sentences” means expect sentences in gold standard. In other words, the mea-
surements precision, recall and F-score ignore the potential affect by “other opinion” cluster
(Om). Note, our measurements only evaluate the correctness of clusters, not the correctness of
the sentences though “incorrect” user comments do exist.
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Drug Accuracy Precision Recall F-score
Metformin 0.675 0.706 0.661 0.683
Clonidine 0.705 0.783 0.696 0.737
Gabapentin 0.665 0.669 0.663 0.680
Clonazepam 0.770 0.766 0.740 0.753
Oxaliplatin 0.655 0.709 0.653 0.680
Prescript-VMC(standard deviation) 0.694(0.05) 0.726(0.05) 0.683(0.04) 0.707(0.04)
Aspirin 0.725 0.768 0.708 0.737
Heparin 0.580 0.635 0.563 0.597
Ibuprofen 0.600 0.634 0.586 0.609
Hydrocodone 0.620 0.665 0.616 0.640
Naproxen 0.575 0.591 0.569 0.580
PRAC(standard deviation) 0.620(0.06) 0.659(0.06) 0.608(0.05) 0.632(0.06)
Overall 0.657 0.693 0.646 0.670
Table 4.1: The performance of the clustering result for all the drugs
Table 4.1 shows the performance of the clustering result by each drug, each category
(prescript-VMC or PRAC) and overall. we can observe the following facts:
 Our semi-supervised PLSA model can achieve a relatively high performance of cluster-
ing. i.e., the overall accuracy is 0:657 and the overall F-score is 0:670, considering the
large number of clusters (9 to 11 per drug).
 Our result also shows that F-score is higher than the corresponding accuracy in all cases.
The paired t-test [81] between F-score and accuracy for the 10 drugs is also significant
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(p-value< 0:05). It indicates that cluster with prior knowledge could effectively improve
the performance than that of no prior knowledge.
 Compared with PRAC medications, Prescript-VMC drugs perform better in all cases.
i.e., accuracy: 0:694 v.s. 0:620, F-score: 0:707 v.s. 0:632, etc. We also conduct t-tests
between PRAC and Prescript-VMC for each of the measurements. It shows, compared to
PRAC, the recall and F-score of Prescript-VMC are significantly higher(p-value< 0:05),
and the accuracy(p-value= 0:06) and recall(p-value= 0:10) are marginally significantly
higher. The results further confirm our conclusion that the clustering on Prescript-VMC
outperforms that of PRAC. This makes sense since people can relatively easily describe
the outcome of Prescript-VMC drugs since they may have more specific treatments, more
strict usage and easier-described side effects.
 Some interesting phenomena: among all the Prescript-VMC drugs, Oxaliplatin, a cancer
chemotherapy drug, is probably the most uncommon one since patients are not likely
to know it unless they are facing colorectal cancer. In contrast, among all the PRAC,
Aspirin is the most popular one since it is a well-known pain-relief that most people
have encountered or heard of. Our results show that the performance of Oxaliplatin is
the worst among all the Prescript-VMC while Aspirin is the best among all the PRAC. It
reveals that: the more people get familiar with a drug, the more accurate that people can
describe its outcomes, thus the better the model achieves the performance.
Also for all the correctly clustered “expert sentences”, we split each group Oi into two sub-
groups Oi sim – showing the similar opinion with the expert’s ei, and Oi opp – showing the
opposite opinion. Two different strategies to form the prior estimator fp(wjei)g are applied
and compared. Table 4.2 shows the accuracy of two approaches compared to the gold standard.
Approach 1 refers to that all meaningful terms are considered while Approach 2 refers to that
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only sentiment terms are considered. We utilize the technique and open source introduced in
Hu and Liu’s sentiment analysis work [82].
Accuracy Approach 1 Approach 2 Change
Prescript-VMC 0.820 0.831 +1.4%
PRAC 0.792 0.811 +2.4%
Overall 0.806 0.821 +1.9%
Table 4.2: The performance of distinguishing Oi sim and Oi opp
From Table 4.2 we observe that both of the approaches reach a high accuracy to determine
the similar or opposite opinion (overall accuracies are above 0:80), which indicates that semi-
supervised PLSA model can successfully solve such problem. Furthermore, compared to the
traditional way to build estimator (Approach 1), the novel way where sentiment analysis is
highly addressed (Approach 2) performs better across Prescript-VMC, PRAC, and overall case.
4.4.4 Case Study
Interface
Eventually, our prototype system is able to provide clustered and integrated drug information
from personal health messages to enable examination through a user-friendly interface 3, whose
composite format for the entire session is shown in Figure 4.3. Users can choose the specific
drug and outcome that they are interested in, and the system will respond to the request by
displaying the topic word distribution, the corresponding expert comment and all the comment
units which belong to this outcome. Each comment unit is labeled by “similar” or “opposite”
and users can also click the link of the corresponding PID to read its complete context.
3Currently the system only works on the 10 drugs used for the evaluation task
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Figure 4.3: Systerm User interface
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Example of Clonazepam
Table 4.4 shows the outcome integration results with expert comments, for the drug Clon-
azepam, which achieves the best performance out of 10 drugs. (accuracy: 0:770, F-score:
0:753). In the table, “Topic model” column shows the most common terms in this outcome as
well as its probability. From this column we expect users could easily conceptualize the partic-
ular cluster at a glance. The third and fourth column show the number of “Similar Opinions”
and “Opposite Opinions” for the corresponding outcome (denoted by s), respectively, as well
as one sample personal sentence (for the space limit).
From Table 4.4, we build 8 clusters for Clonazepam, where each of them focuses on one
meaningful semantic outcome, guided by an expert comment. For example, Outcome ID 1
talks about the main treatment of Clonazepam – to treat seizures, which we know from the
topic model and the expert comment e1. 59 comments express the similar/same opinion, while
other 16 show different/opposite opinions on the same topic. From each row, we could easily
understand the general user experience and how common this experience are among users
regarding the particular outcome while taking Clonazepam: how do they feel about this drug?
Do they agree or disagree with the expert’s? Similarly, the rest outcomes such as side effects,
dosage are shown in the following rows.
Such information is scattered in the huge amount of messages and impossible to integrate
by hand without our system. Reading such information, audiences may find our system can
effectively collect, organize and integrate the drug-based information and display it in a well-
readable way.
New discovery of “other outcome”
Note for each drug, we also generate an additional cluster Om, i.e., “other outcome” which
includes information mentioned by online users but not in standard description from expert
comments. Table 4.3 shows some sentences (31 sentences in total, of which 8 relate to mouth
burning) in Om for Clonazepam.
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He said klonopin would help the burning sensation so I tried it and it did.
The Klonopin is the only drug that helped me with the burning taste.
We reintroduced the klonopin in a dropper full of water
sublingually and eventually stabilized.
...
Table 4.3: Sample results of Om for Clonazepam
We examine this cluster for each drug and find some interesting opinions. e.g., 34 com-
ments report that Metformin is also used to treat obesity. For Clonazepam, 8 sentences show
that Clonazepam may help to relief stomatodynia (burning mouth syndrome). For Aspirin, 5
sentences say that taking Aspirin causes eye problem, such as bursting eye vessels. For Hep-
arin, 6 sentences show the concern that Heparin may cause severe bleeding to death. etc.
Although such “other outcomes” are not mentioned in expert comments, i.e., not recorded
as standard outcome of the drug, they are discussed by actual users. In fact, formal medical
literatures have mentioned each of the above additional outcomes – Metformin [83], Clon-
azepam [84], Aspirin [85] and Heparin [86]. Therefore, our system can effectively discover
such “new outcome” from the clinical experiences as reported directly by the patients, which
will provide supplemental information for the drug’s standard description.
4.4.5 Advantages and Limitations of Model
One advantage of our system over other simple statistic methods relies on its capacity of cap-
turing the coherence of terms (e.g., appositive, synonym). The PLSA model is able to detect
such connection between two comments which contain relevant, but not identical information
since they share the similar contexts. Take one of the Clonazepam’s outcomes (OID 4) as an
example, the expert comment is “Follow ... and ask your doctor or pharmacist to explain any
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part you do not understand.” The 18 similar sentences include not only “I would like to discuss
with my Doctor...” which capture the word “doctor” exactly, but also “I first tried Klonapam
prescribed by Dr. Cheney”, and “you need to be monitored by a physician”, which capture the
word “dr”, “physician”.
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OID Topic model Expert comment Similar Opinions Opposite Opinions
1
seizures(0.10)
panic(0.09), attacks(0.07)
seizure(0.06), brain(0.05)
activity(0.02)
Clonazepam is used alone or in combination
with other medications to control certain type of
seizures. It is also used to relieve panic attacks
and works by decreasing abnormal electrical
activity in the brain.
[s=59] She has only had a
handful of seizures since
then, Klonopin seems to
control her seizures well
[s=16] Shy, Klonopin did
not seem to contribute
to my brain fog.
2
disorder(0.05),
restless(0.04), plmd(0.03)
dystonia(0.03)
movement(0.02)
mental(0.02)
Clonazepam is also used to treat symptoms of
akathisia that may occur as a side effect of
treatment with anti-psychotic medications and
to treat PLMD , dystonia, and acute catatonic
reactions)
[s=26] Klonopin works
really well for Periodic
Limb Movement Disorder,
or any other med in the
benzo class.
[s=12] Tried clonazepam
for stress induced issues
but it was too strong for me
3
times(0.09), mg(0.08)
daily(0.07), three(0.06)
bedtime(0.04)
tablet(0.03)
Clonazepam comes as a tablet to take by mouth.
It usually is taken one to three times a day
with or without food. Take clonazepam at
around the same time(s) every day.
[s=33] Zach has been on
Klonopin .5mg three times
a day for years
[s=9] Please do not take
more than 8 Klonopin
tablets a month
4
doctor(0.03), ask(0.02)
prescription(0.02)
dr(0.02), explain(0.01)
pharmacist(0.01)
Follow the directions on your prescription label
carefully, and ask your doctor or pharmacist
to explain any part you do not understand.
[s=18] Patricia, Klonopin is
the best medication to take
, but you need to be
monitored by a physician.
[s=6] I know they can’t
prescribe the klonopin but
a recommendation would
be helpful.
5
allergic(0.07)
pregnant(0.06)
allergic(0.06),
myoclonus(0.05)
pregnancy(0.02)
Before taking clonazepam, tell your doctor
if you are allergic to clonazepam, tell
your doctor if you are pregnant.
[s=24] Most anti-seizure
meds aren’t allowed to
be taken while you are
pregnant,like Klonopin
[s=20] Sydnie has never
had any allergy from
the klonopin so we have
been pretty pleased with it!
6
anxiety(0.21), anti(0.04)
depression(0.03)
mood(0.02)
emotional(0.02)
suicide(0.02)
Report any new or worsening symptoms such as
mood or behavior changes, or if you feel
agitated, irritable, hostile, aggressive, or have
thoughts about suicide or hurting yourself.
[s=55] I have been worried
about taking the Klonopin
for the anxiety and
sleeplessness because I have
this history of depression.
[s=26] I just started taking
Klonopin a couple of
months ago for my
anxiety.
7
tired(0.05), redness(0.04)
rash(0.03), eye(0.02)
breathing(0.02)
liver(0.02)
Call your doctor if you have a serious side effect
such as: tiredness, shallow breathing; unusual
eye movements; stomach problem, liver or
kidney problem, redness, abnormal weight
[s=23] The klonopin just
made me tired and that kind
of made me feel more
out of control.
[s=8] Only on the left side,
and it is more like
a rash than a redness
8
addiction(0.14)
abuse(0.13)
addictive(0.07)
highly(0.02)
pregnancy(0.02)
Clonazepam may cause someone drug abuse or
addiction.
[s=31] Unfortunately,
Klonopin is a very addictive
drug.
[s=9] Klonopin is a little
addictive, but does help
when you need it
Table 4.4: The outcome results for Clonazepam with expert comments
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Another advantage of the model is the flexibility of setting expert comments. Users can
follow our example, i.e., extracting E from a professional drug database, or define and input
the expert comments by themselves as prior knowledge of PLSA model. The clustering results
will vary according to different expert comments. This customizable design could cater to
users’ various information need.
PLSA model requires to manually set a fixed number of clusters and lacks a way to dynam-
ically determine the proper number of clusters. We will try to solve the problem in the future
work. Furthermore, our model can analyze each independent drug effectively by embedding its
specific expert comments. However, a unified expert-comment setting strategy should be de-
signed and implemented while extending our system to the universal drugs or even treatments.
To sum up, our outcomes system is accurate for clustering standard outcomes and effective
for discovering novel outcomes, while is fully automatic with text processing. Thus by using
this interactive system as the core engine,we believe a national wide surveillance system for
drug-related outcomes is highly feasible.
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4.5 Conclusion and Future Work
In this chapter, I describe a useful system we built to cluster and integrate drug-based medical
information. PLSA model and sentiment analysis techniques are applied in the system. We de-
sign a large-scale and professional-quality annotation framework, the output of which is good
enough to be the gold standard to test the performance of the model. The experiment result-
s with high accuracy and F-score show that our system can successfully organize the online
medical information in a meaningful way. Users can request and search the well-organized
personal opinions on different types of drugs via our prototype system, which could satisfy not
only physicians’, but also patients’ information need.
In the future, we plan to explore and analyze different online healthcare resources, such
as twitter4 – a more general social network where people discuss their health problem in a ca-
sual way, or MedHelp5 – a more professional medical forum providing well documented user
demographic information (the utilization of MedHelp is in Section 5). We also expect to com-
pare the up-to-date contents and language features across different online medical discussion
platforms.
From a system perspective, we will design and implement a flexible expert-comment setting
strategy which offers the choice of unified standard from expert resource or patient-oriented
prior knowledge. Building upon the clustering engine described in this paper, a wide range
of drugs and treatments can be automatically analyzed from patient-specified personal health
messages, and an effective interactive system can be built upon their integrated results.
4http://www.twitter.com
5http://www.medhelp.org/forums/list/
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CHAPTER 5
Comparative Effectiveness
Research(CER) Hypothesis Prediction in
Personal Health Messages
In this section, I will introduce our latest project – conducting comparative effectiveness re-
search (CER) hypothesis by analyzing personal health messages.
According to Institute of Medicine, comparative effectiveness research (CER) is defined as
the generation and synthesis of evidence that compares the benefits and harms of alternative
methods to prevent, diagnose, treat, and monitor a clinical condition or to improve the delivery
of care [1]. By answering the core question of “which treatment works best for whom and under
what circumstances”, the research results could assist consumers, care providers, researchers
and policy makers to make informed health care decisions. In the year 2009, US$ 1:1 billion of
government funding was earmarked for CER research. Since then, increasing research effort
and organizational leaderships have emerged national-wide to push forward this research field.
Similar to other medical research, CER research embraces the methodology of clinical trial.
Difficulties, however, are posed by the nature of CER research, as it focuses on the comparisons
“for whom” and “under what circumstances”. Given the numerous demographical and condi-
tional variables and their potential combinations, it is simply impossible to exhaustively include
all of them in the comparative testing in expectation of opportunistic results. However, if the
researchers could possibly identify variables with highest potential to see a difference, they
may prioritize them by selectively including, thus largely decreasing the number of variables
in the clinical trial. In this paper, we argue that mining opinions about alternative treatments
from large repository of online health messages posted by real users could be a promising way
to serve that purpose.
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The popularity of Web 2:0 technology has made internet a common platform for people to
express, share and discuss their opinions. As a result, the Internet provides rich resource for
researchers and analysts to mining public opinions, which, in many fields, has proved itself to
be an equivalent, or even preferred approach to other time and labor consuming methods such
as polling or longitude data logging.
Health related topic is one of the most discussed topics on the internet. There exist many
social media services dedicated to health related discussions. Also many health information
websites include components that allows user generated contents such as user review system
for medication website. Frequently people share their first-hand experience with various treat-
ments or offer suggestions to other patients who seek for opinions. By aggregating these indi-
vidual messages regarding specific treatment, one could potentially get rich data from a sample
that is potentially well distributed in the population, given that nowadays Internet is frequently
used by people of various age, gender, race, income, geographical location, etc. Therefore,
it is possible to compare multiple treatments by comparing the collective opinions on each of
them. The results could supplement the conclusions of formal CER research, or serve as basis
for forming hypothesis for clinical research.
The great quantity of health messages available on the internet enables various forms of
medical analysis, which can be extremely time consuming or even impossible with traditional
data collecting methods. For example, Yahoo Groups! contains more than 100million personal
messages spanning over 20 years that are relevant to health and medical domain. MedHelp
contains over 10 million messages covering more than 100 medical topics, etc. Compared
with electronic medical record (EMR), though possibly less accurate, the scale of online health
messages makes it possible to carry on population based medical-related research, such as CER
prediction.
Furthermore, online health messages enable data collection by individual case, which could
provide contextual information about the particular patient, including his or her demographical
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information, social information and health profile. These kinds of information are valuable for
informing medical research, especially CER research, for which individual difference is the
core research focus. This individual contextual information could be derived either explicitly,
by directly extracting from user filled profile, or implicitly, by tracking historical user generated
content or behavioral data. In this paper we focus on the former, although the same technique
could be applied as long as individual specific contextual information is identifiable.
Nowadays, It is a common practice that users fill out a profile page on social media website,
which often specifies the basic demographical information. Utilizing this information enables
us to aggregate opinions by demographical variables, which seems to be especially relevant
and useful for informing CER research. For example, if one could find evidence from the user
opinions that only a certain age group of users favor treatment A more than treatment B, then
this observation could serve as the hypothesis for clinical trial and comparative testing among
this particular group could be prioritized among all age groups.
In this paper, we present a study that, by first extracting treatment specific opinions from
MedHelp 1, a large and professional dataset of online health messages, then evaluating these
opinions by either machine enabled sentiment analysis or human analysts which targets to the
treatments of two common diseases: breast cancer and depression, we were able to generate
evidence that could be used by CER research. By suggesting three different methods (i.e.
direct comparison by the same author, indirect comparison by the same author and indirect
comparison in overall case) to conduct the opinions comparison, we attempted to draw reliable
conclusions that are strengthened by multiple evidences. Specifically, from the personal pro-
file page, we were able to track the demographic information of the opinion source, including
age, gender and geographical location. We proved that, by aggregating user opinions based
on these variables, we were able to identify demographical characteristics for which candi-
1http://www.medhelp.org/
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date treatments are most likely to show differences. Theses results could serve as preliminary
evidence for “which treatment works best for whom”.
The section of work is complete and is submitted to the journal of ACM Transactions of
Management Information Systems (ACM-TMIS), Special Issue for Smart Health and Well
Being, to appear in 2013.
Organization. Section 5.1 defines the problems, objectives and setup of the work. Sec-
tion 5.2 shows all the experiment results as well as statistical testing and is followed by the
discussion of limitation in Section 5.3. Finally, I will make conclusion and discuss the future
work in Section 5.4.
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5.1 Problem Definition
5.1.1 Setup
We choose all posts on MedHelp 2 as our dataset. MedHelp is a on online forum where pa-
tients and providers discuss various health related topics. As its name suggests, commonly
people posts questions regarding specific health problem and seek for help from other patients
or providers. The site listed more than 100 registered providers who frequently visit the site
and preside a number of ”expert forums” to answer patients’ questions. By 2009, this site was
getting over 6 million unique visitors monthly, and contained more than 10 million messages.
Compared to other social media sites that are less dedicated to health discussion, such as Yahoo
Answer! or Twitter, MedHelp contains significantly more focused and informative discussions
contributed by experienced patients and care providers, while less noised data such as spam-
ming and irrelevant discussions. Therefore, we believe this site offers us a rich and relatively
clean dataset for extracting and comparing opinions regarding different treatments.
We choose breast cancer and depression as our CER objects. Both diseases are fairly com-
mon and raise great public attention in US. More than 200; 000American women are diagnosed
annually with breast cancer [87] and millions of American adults are diagnosed annually with
depression. Particularly, the effectiveness comparisons among different treatments for breast
cancer and depression are listed as top 100 CER candidates by Institute of Medicine of the
National Academy [88].
Disease 1: Breast Cancer
There are two specific sub-forums on MedHelp which are related to breast cancer: Breast
Cancer and Breast Cancer Expert. Table 5.1 shows some general statistics of the sub-forums.
2http://www.medhelp.org/
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Sub-forum name Total personal messages Unique authors
Breast Cancer 45646 11870
Breast Cancer Expert 24860 8027
Overall 70506 17904
Table 5.1: The general statistics of breast cancer sub-forums
For breast cancer, we will compare the effectiveness between each two of the following
common treatments: Chemotherapy, Radiation Therapy, and Hormonal Therapy. These are
most widely-applied treatments for breast cancer and we aim to see how the actual users show
preferences between: (i.e. Chemo v.s. Radiation, Chemo v.s. Hormonal, Radiation v.s. Hor-
monal).
Disease 2: Depression & Anxiety
There are three specific sub-forums on MedHelp which are related to depression: Anxiety,
Depression and Depression Expert. Table 5.2 shows some general statistics of the sub-forums.
Sub-forum name Total personal messages Unique authors
Anxiety 116321 20817
Depression 40762 10340
Depression Expert 29112 10072
Overall 186195 38643
Table 5.2: The general statistics of depression sub-forums
For depression & anxiety, we will compare the effectiveness between Meditation Therapy
(e.g., yoga, deep breath training, etc) and the traditional medicine treatments. There are three
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commonmedicine classes to treat depression & anxiety: Selective serotonin reuptake inhibitors
(SSRIs); Serotonin and norepinephrine reuptake inhibitors (SNRIs) and Tricyclic antidepres-
sants (TCAs). In the experiment, we will compare meditation treatment with each of the three
medicine treatments, respectively.
5.1.2 Design
To analyze the opinion on the treatment effectiveness of the author 3, we need to extract the
useful part of the messages which can exactly capture the opinion. On one hand, typically
an author describes different things and shows multiple opinions in one single message, thus
analyzing the whole message’s opinion (positive, negative or neutral) may bias the opinion
on one specific treatment. On the other hand, only analyzing the exact sentence where the
treatment appears may miss some key information which appears in the context of the sentence.
Therefore, we analyze the sentence containing the keywords of the specific treatment, as well
as its treatment-keywords-free context, called comment unit.
The keywords of each treatment we applied are listed in Table 5.3.
3Here one author is referred to a patient who posted messages on the forum
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treatment Chemotherapy Radiation Hormonal Meditation SSRI SNRI TCA
disease Breast Cancer Breast
Cancer
Breast Cancer Depression Depression Depression Depression
keywords
Chemotherapy
chemo
Abraxane, paclitaxel
Adriamycin
doxorubicin
carboplatin
Paraplatin, Cytoxan
cyclophosphamide
daunorubicin
Cerubidine
DaunoXome, Doxil
doxorubicin, Ellence
epirubicin, Halaven
fluorouracil
5-fluorouracil, 5-FU
Adrucil, Gemzar
gemcitabine,
eribulin, Ixempra
ixabepilone
methotrexate
Amethopterin,
Folex, Mitomycin
mutamycin,Mexate
mitoxantrone
Navelbine
Novantrone,
vinorelbine, Taxol
paclitaxel, Taxotere
docetaxel, thiotepa
Thioplex, vincristine
Oncovin, Vincrex
Xeloda, capecitabine
AC, CMF, CEF
FAC, CAF, TAC
AC-T, AC
radiation
radiotherapy
XRT
DXT
hormonal
Aromatase inhibitor
Aromatase inhibitors
AIs
Arimidex
anastrozole
Aromasin
exemestane
Femara
letrozole
Selective Estrogen
Receptor Modulators
Selective Estrogen
Receptor Modulator
Serms
serm
tamoxifen
Nolvadex
Evista
raloxifene
Fareston
toremifene
ERDs
erd
Estrogen-Receptor
Downregulators
Estrogen-Receptor
Downregulator
Estrogen Receptor
Downregulators
Estrogen Receptor
Downregulator
faslodex
fulvestrant
mindfulness
mindfulness-
based
yoga
yoga-based
meditation
meditations
deep breathing
deep breath
breath training
breathing-
training
deep breath-
training
Selective-
serotonin-
reuptake-
inhibitor
Selective-
serotonin-
reuptake-
inhibitors
SSRIs
SSRI
fluoxetine
Prozac
Sarafem
paroxetine
Paxil
Pexeva
sertraline
Zoloft
citalopram
Celexa
escitalopram
Lexapro
Symbyax
norepinephrine-
reuptake-
inhibitors
norepinephrine-
reuptake-
inhibitor
SNRI
SNRIs
duloxetine
Cymbalta
Yentreve
venlafaxine
Effexor
Effexor XR
desvenlafaxine
Pristiq
Milnacipran
Dalcipran
Ixel
Savella
Levomilnacipran
F2695
Tricyclic-
antidepressants
Tricyclic-
antidepressant
TCAs
TCA
Amitriptyline
Elavil
Endep
Clomipramine
Anafranil
Doxepin
Adapin
Sinequan
Imipramine
Tofranil
Trimipramine
Surmontil
Table 5.3: The keywords for each treatment
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5.1.3 Direct Comparison by Same Author
To judge an author’s preference on two treatments, the most straightforward approach is to
detect her direct comparison (e.g. I prefer chemo to radiation; I think taking duloxetine is
worse than yoga treatment. etc). We describe out first comparison method, direct comparison
by same author, in this section. For each pair of treatments to be compared, we collect all the
authors who have written at least one sentence in which both of the treatments were mentioned.
For each extracted comment unit and the treatment T1 and T2, one author may have one
of the four cases of preference: (1). prefer T1 to T2, (2). prefer T2 to T1. (3). T1 and T2
are equally considered. (4). No direct comparison. We invited 5 medical school students
who are experienced, and familiar with information about drugs and treatments, among other
qualifications to annotate all the comment units. For time and quality concern, it is impossible
to ask one judge to label all the sentences so we randomly split the whole annotation task to
the 5 judges. We used the following coding scheme to instruct the judges.
For two treatments T1 and T2, we say T1 is preferred when:
 T1 and T2 have both been taken and T1 is clearly mentioned that it is better, or has less
side effects than T2.
 T1 and T2 have both been taken and T1 is clearly mentioned that it works well, while no
words for T2.
 T1 and T2 have both been taken and T2 is clearly mentioned that it works bad, while no
words for T1.
we say T2 is preferred when:
 T1 and T2 have both been taken and T2 is clearly mentioned that it is better, or has less
side effects than T1.
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 T1 and T2 have both been taken and T2 is clearly mentioned that it works well, while no
words for T1.
 T1 and T2 have both been taken and T1 is clearly mentioned that it works bad, while no
words for T2.
and we say T1 and T2 are equally considered when:
 T1 and T2 have both been taken and there is no significant preference on their outcomes.
 T1 and T2 have both been taken and both of T1 and T2 are praised.
 T1 and T2 have both been taken and both of T1 and T2 are complained.
finally, T1 are T2 are considered no comparison when:
 T1 and T2 have been taken but the author says nothing about the outcome of T1 or T2.
 T1 and T2 are only mentioned in the sentence. We don’t know whether they have been
taken or not.
To test the inter-judge reliability, we assigned them 50 identical sentences, which are ran-
domly selected from the sentence pool. we test the inter-rater agreement by using Fleiss’
kappa [79]. Fleiss’ kappa is widely used for assessing the reliability of agreement between a
fixed number oef judges when assigning categorical ratings to a number of items or classify-
ing items. For our experiment, Fleiss’ kappa value reaches 0:82, which is considered almost
perfect agreement.
The above results indicate that there is no significant variance among all the annotators.
Therefore, we can confidently utilize the annotated results to judge the preference of each
author.
Specifically, if an author has posted more than one such sentences, we will decide the
author’s preference based on all the sentences. If there are opposite opinions – i.e. In one
58
sentence, T1 is preferred while in another sentence, T2 is preferred, we will dismiss such
author since she has inconsistent opinion. After labeling all the comment units, no such author
is found, indicating that direct comparison between two treatments is always consistent by the
same author.
5.1.4 Indirect Comparison by Same Author
In many cases, authors may not directly compare two treatments in one sentence but may men-
tion their effectiveness respectively in different posts. For instance, if one author continually
mentions that T1 is good for her in some posts, while she mentions that T2 has severe side
effects in other posts. We can claim that this author prefer T1 to T2. Although there is no
direct comparison, such indirect comparison can also reveal one author’s preference.
In this section, we describe the second comparison method, indirect comparison by same
author. For each pair of comparable treatments, we collect all the authors who have written
sentences related to both of the treatments, respectively. To remove the influence of the direct
comparison, the sentences analyzed by Section 5.1.3 will not be considered. We only count the
authors who have mentioned T1 and T2 in different sentences.
For each author, we collect two sets: S1 and S2, composed by the comment units where
T1 and T2 appears, respectively. Pennebaker and Campbell discovered that the words people
use have strong correlation with their physical and mental health [89]. Thus, for S1 and S2,
we utilize LIWC – effective sentiment analysis tool [90] to determine the opinion of the author
– does she have positive, negative or neutral opinion on one specific treatment, by processing
each comment unit in the set. LIWC has been utilized to compare the language usages between
depressed and depressions-vulnerable students [91].
Similarly, we examined the consistency of each author’s preference on one specific treat-
ment across the whole dataset. If there are opposite opinions – i.e., in one sentence, it shows
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positive opinion on Treatment 1 while it shows negative opinion on the same treatment some-
where else, we will remove such author in the analysis since he or she has inconsistent opinion.
For all the authors who have consistent opinions on T1 and T2, we indirectly interpret their
preferences on T1 and T2 based on the following criteria:
We say T1 is preferred when:
 The author has positive opinion on T1 and negative opinion on T2.
 The author has positive opinion on T1 and neutral opinion on T2.
 The author has neutral opinion on T1 and negative opinion on T2.
we say T2 is preferred when:
 The author has positive opinion on T2 and negative opinion on T1.
 The author has positive opinion on T2 and neutral opinion on T1.
 The author has neutral opinion on T2 and negative opinion on T1.
and we say T1 and T2 are equally considered when:
 The author has positive opinion on T1 and T2.
 The author has negative opinion on T1 and T2.
 The author has neutral opinion on T1 and T2.
5.1.5 Indirect Comparison in Overall Case
In this section,we describe the third comparison method, indirect comparison in overall case.
We will indirectly compare two treatments based on the opinion of the overall population –
i.e., we only care how many people favor or unfavor one specific treatment. That is, we only
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analyze the overall opinions for each treatment. Compared with the previous two experiments,
this method may have the weakest power to reveal the comparison of two treatments since the
two groups of people may differ, and some people may simply try only one treatment thus have
no comparison.
Different from Experiment the previous two, in this experiment, we treat each treatment
separately – collecting the authors who have posted sentences relative to one specific treatment
T . LIWC is also applied to determine the opinion of each author on one treatment.
5.1.6 Demographic Analysis
In the above sections, we only consider the preference of overall population. However, people’s
preferences can be diverse according to the different demographic categories [92], e.g., gender,
age, region, race, income, etc. In the following session, we want to explore the potential
difference of different demographic groups to answer the following questions: What is the
preference of two treatments, for a specific demographic group? Is it same as the overall case,
or different? How to compare the attitude of one treatment between two demographic groups?
Is there any group significantly in higher favor of one treatment than other groups?
Some of the MedHelp users reveal detailed demographic information in their user pro-
files. After observing their profiles, we choose the following categories to be the representative
groups:
 Gender: Male or Female. Note we only apply gender analysis on depression, not on
breast cancer since the overwhelming majority of breast cancer patients are female .
 Age: We separate people into 4 groups: Age under 29, 30  49, 50  64, over 65.
 Region: Northeast, Midwest, South andWest. This regional divisions are used by United
States Census Bureau [93].
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To answer the first question: what is the preference of two treatments, for a specific demo-
graphic group, we will do an inner-group experiment. For one specific group, we will calculate
the portion of people who have positive/negative/neutual attitude on one specific treatment.
And then comparing a pair of treatments using the approach in Section 5.1.5. The only differ-
ence between this experiment and Section 5.1.5 is the range of people investigated.
To answer the second question: how to compare the attitude of one treatment between two
demographic groups, we will do a cross-group experiment. Using the information of each
group’s opinions on single treatment, we will compare the opinion difference between two
corresponding groups upon the same treatment. e.g., which group favors Radiation more? Age
30  49 or Age 50  64?
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5.2 Results
5.2.1 Experiment A: Direct Comparison by Same Author
Table 5.4 shows the direct comparison results for each pair of treatments.
Disease Breast Cancer Breast Cancer Breast Cancer Depression Depression Depression
Treatment 1 Chemo Chemo Radiation Meditation Meditation Meditation
Treatment 2 Radiation Hormonal Hormonal SSRI SNRI TCA
# of authors mentioning
T1 and T2, simultaneously
987 302 329 22 4 0
# of authors having no
comparison
274 60 62 0 0 N/A
# of authors having com-
parison
713 242 267 22 4 N/A
# of authors preferring T1 62 58 66 8 3 N/A
percentage 8.70% 23.97% 24.72% 36.36% 75% N/A
# of authors preferring T2 21 25 23 1 0 N/A
percentage 2.95% 10.33% 8.61% 4.54% 0 N/A
# of authors equally con-
sidering T1 & T2
630 159 178 13 1 N/A
percentage 88.36% 65.70% 66.67% 59.09% 25% N/A
Table 5.4: The results of Direct Comparison by author
From the data above, we can observe that for depression, people rarely directly compare
a depression drug and meditation treatment in one sentence. In contrast, people frequently
mention chemo, hormonal and radiation treatment in one sentence. It is reasonable since med-
itation and depression drugs have significant difference in treatment history, mechanism, etc,
while chemo, hormonal, and radiation are usually be treated as a combination when the patient
has breast cancer, thus co-mentioned frequently.
We also observe that in Table 5.4, in all available treatment pairs, The portion which prefers
T1 is always larger than the portion which prefers T2 (e.g., for breast cancer, when comparing
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Chemo and Hormonal, 23:97% authors prefer Chemo (T1), while only 10:33% authors prefer
Hormonal (T2)).
To statistically test the preference of two treatments, we first run a chi-square test [94]
to test the hypothesis: the three categories(preferring T1, preferring T2, T1 and T2 equally
considering) have the equal counts. The test evaluates the null hypotheses that people’s prefer-
ences are equally distributed in the three categories mentioned above. Based on the chi-square
definition, the chi-square test statistic is denoted as:
2 =
3X
i=1
(Ni   piN)2
p1N
(5.1)
In the above formula, given total count N , Ni refers the observed counts of each category
which are to be compared to the expected counts piN whereas p1 = p2 = p3 = 1=3. Table 5.5
shows the chi-square test results for all the comparative treatments.
Disease Breast Cancer Breast Cancer Breast Cancer Depression Depression
Treatment 1 Chemo Chemo Radiation Meditation Meditation
Treatment 2 Radiation Hormonal Hormonal SSRI SNRI
N 713 242 267 22 4
N1 62 58 66 8 3
N2 21 25 23 1 0
N3 630 159 178 13 1
2 975.0 120.8 143.9 9.9 3.5
degree of freedom 2 2 2 2 2
p-value < 10 4 < 10 4 < 10 4 0.007 0.17
judgement significant significant significant significant not significant
Table 5.5: The chi-square test results of Direct Comparison by author
From Table 5.5 we observe that for all the treatment pairs except Meditation and TCA,
there exists significantly unequal counts for some of the three categories. We therefore conduct
post-hoc pairwise analysis to compare each pair of categories. For the purpose of our study, we
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focus on presenting the proportion test [95] between the two groups:those preferring T1 and
those preferring T2. We use p1, p2 to denote the portion of preferring T1 group and preferring
T2 group, respectively.
Table 5.6 shows the proportion test results for all the comparative treatments.
Disease Breast Cancer Breast Cancer Breast Cancer Depression Depression
Treatment 1 Chemo Chemo Radiation Meditation Meditation
Treatment 2 Radiation Hormonal Hormonal SSRI SNRIa
N 83 83 89 9 4
N1 62 58 66 8 3
p1 0.75 0.70 0.74 0.89 0.75
N2 21 25 23 1 0
p2 0.25 0.30 0.26 0.11 0.25
 0.055 0.055 0.053 0.167 N/A
z 4.50 3.62 4.56 2.33 N/A
p-value < 10 4 1:5  10 4 < 10 4 0.01 N/A
judgement significant significant significant significant N/A
 = p0  (1  p0)=N , p0 = 0:5
z = (p1   p0)=
aAccording to the definition of proportion test, the sample should include at least 5 items in each group. Therefore the proportion test is
not applied for this pair.
Table 5.6: The proportion test results of Direct Comparison by author
From Table 5.6 we observed that all the applied pairs show p1 is significantly larger than
p2, indicating that the number of authors who preferred Treatment 1 is significantly more than
that of Treatment 2, for each case.
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5.2.2 Experiment B: Indirect Comparison by Same Author
From the results in Section 5.2.1, although direct comparison by the same author captures
the most direct and possibly most accurate preference of the patients, we observe that the
number of patients who directly compare treatments are relatively small, even none in some
cases. Therefore, we conduct indirect comparison by the same author to increase the number
of available cases.
Table 5.7 shows the indirect comparison results for each pair of treatments.
Disease Breast Cancer Breast Cancer Breast Cancer Depression Depression Depression
Treatment 1 Chemo Chemo Radiation Meditation Meditation Meditation
Treatment 2 Radiation Hormonal Hormonal SSRI SNRI TCA
total # of authors mentioning T1 and T2 1330 717 719 663 282 72
# of authors mentioning T1 and T2, respec-
tively
562 529 505 654 278 72
# of authors having consistent judgement on
T1 and T2
352 322 314 284 113 29
# of authors: Positive on T1; Negative on T2 15 13 21 60 20 6
# of authors: Positive on T1; Neutral on T2 45 44 39 37 21 5
# of authors: Neutral on T1; Negative on T2 40 32 37 30 8 6
# of authors preferring T1 to T2 100 89 97 124 49 17
percentage 28.41% 27.64% 30.90% 44.72% 43.36% 58.62%
# of authors: Neutral on T1; Positive on T2 46 28 37 10 9 2
# of authors: Negative on T1; Neutral on T2 22 28 20 21 10 2
# of authors: Negative on T1; Positive on T2 11 10 10 10 8 3
# of authors preferring T2 to T1 79 66 67 41 27 7
percentage 22.44% 20.50% 21.34% 14.44% 23.89% 24.14%
# of authors: Neutral on T1; Neutral on T2 106 103 85 28 7 2
# of authors: Positive on T1; Positive on T2 50 40 43 17 11 1
# of authors: Negative on T1; Negative on
T2
17 24 22 71 19 2
# of authors equally considering T1 & T2 173 167 150 116 37 5
percentage 49.15% 51.86% 47.77% 40.85% 32.74% 17.24%
Table 5.7: The results of Indirect Comparison by author
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Compared with Table 5.4, Table 5.7 shows there are more data available for indirect com-
parison of treatments in all cases, which suggested potentially increased validity of the conclu-
sion.
Similar to Section 5.2.1, from the result of indirect comparison by the same author, We
also observe that in Table 5.7, in all available treatment pairs, The portion which prefers T1 is
always larger than the portion which prefers T2 (e.g., for depression, when comparing Media-
tion and SNRI, 43:36% authors prefer Mediation (T1), while only 23:89% authors prefer SNRI
(T2)).
Similarly, we start by running a chi-square test [94] to test the hypothesis: the three cat-
egories(preferring T1, preferring T2, T1 and T2 equally considering) have the equal counts.
Based on the chi-square definition in Formula 5.1. Table 5.8 shows the chi-square test results
for all the comparative treatments.
Disease Breast Cancer Breast Cancer Breast Cancer Depression Depression Depression
Treatment 1 Chemo Chemo Radiation Meditation Meditation Meditation
Treatment 2 Radiation Hormonal Hormonal SSRI SNRI TCA
N 352 322 314 284 113 29
N1 100 89 97 124 49 17
N2 79 66 67 41 27 7
N3 173 167 150 116 37 5
2 41.49 52.22 33.75 46.27 6.44 8.55
degree of freedom 2 2 2 2 2 2
p-value < 10 4 < 10 4 < 10 4 < 10 4 0.04 0.013
judgement significant significant significant significant significant significant
Table 5.8: The chi-square test results of Indirect Comparison by author
From Table 5.8 we observe that for all the treatment pairs, the hypothesisH0 will be reject-
ed, i.e. there exists significantly unequal counts among some pair of the categories. We then
conducted posthoc pairwise comparison. The tests results comparing the category of preferring
T1 and the category preferring T2 are shown in Table 5.9 .
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Disease Breast Cancer Breast Cancer Breast Cancer Depression Depression Depression
Treatment 1 Chemo Chemo Radiation Meditation Meditation Meditation
Treatment 2 Radiation Hormonal Hormonal SSRI SNRIa TCA
N 179 155 164 168 76 24
N1 100 89 97 124 49 17
p1 0.559 0.574 0.591 0.756 0.645 0.708
N2 79 66 67 41 27 7
p2 0.441 0.426 0.409 0.244 0.355 0.292
 0.037 0.040 0.039 0.039 0.057 0.102
z 1.57 1.85 2.34 6.64 2.52 2.14
p-value 0.05 0.03 0.01 < 10 4 0.006 0.012
judgement significant significant significant significant significant significant
 = p0  (1  p0)=N , p0 = 0:5
z = (p1   p0)=
Table 5.9: The proportion test results of Indirect Comparison by author
From Table 5.9 we observe that in all the pairs p1 is significantly larger than p2, indicating
that the number of authors who preferred Treatment 1 is significantly more than that of Treat-
ment 2, for each case. The conclusion is consistent with the one we draw from Section 5.2.1.
68
5.2.3 Experiment C: Indirect Comparison in Overall Case
For indirect comparison, we focus on comparing the overall attitude expressed for each treat-
ment, instead of detecting each author’s preference between two treatments. Table 5.10 shows
the descriptive results.
Disease Breast Cancer Breast Cancer Breast Cancer Depression Depression Depression Depression
Treatment T Chemo Radiation Hormonal Meditation SSRI SNRI TCA
# of authors mention-
ing T
2476 2154 1486 1454 10996 4131 473
# of authors having
positive opinion on T
1043 851 505 653 2146 877 112
percentage 42.12% 39.51% 33.98% 44.91% 19.52% 21.23% 23.68%
# of authors having
negative opinion on T
651 614 522 518 6499 2248 263
percentage 26.29% 28.50% 35.13% 35.63% 59.10% 54.42% 55.60%
# of authors having
neutral opinion on T
782 689 459 283 2351 1006 98
percentage 31.58% 31.99% 30.89% 19.46% 21.38% 24.35% 20.72%
Table 5.10: The results of Indirect Comparison in overall
Different from Section 5.2.1 and 5.2.2, we conducted different statistical analysis to inves-
tigate the preference of the overall people:
For each pair of treatments T1 and T2, given
 p1pos: the percentage of authors having positive opinion on T1
 p2pos: the percentage of authors having positive opinion on T2
 p1neg: the percentage of authors having negative opinion on T1
 p2neg: the percentage of authors having negative opinion on T2
, if more people are positive on T1 meanwhile fewer people are negative on T1, i.e., p1pos
is significantly larger than p2pos , meanwhile p1neg is significantly smaller than p2neg, we can
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conclude that the number of authors who hold positive attitude towards T1 is significantly more
than that of T2.
To compare two independent portions from two samples (p1pos and p2pos, p2neg and p2neg),
we run a two-sample proportion test. Table 5.11 and 5.12 show the two-sample proportion test
result for positive and negative attitude in overall people, respectively.
Disease Breast Cancer Breast Cancer Breast Cancer Depression Depression Depression
Treatment 1 Chemo Chemo Radiation Meditation Meditation Meditation
Treatment 2 Radiation Hormonal Hormonal SSRI SNRIa TCA
N1 2476 2476 2154 1454 1454 1454
N2 2154 1486 1486 10996 4131 473
p1pos 42.12% 42.12% 39.51% 44.91% 44.91% 44.91%
p2pos 39.51% 33.98% 33.98% 19.52% 21.23% 23.68%
p 0.409 0.391 0.373 0.225 0.274 0.40
 0.014 0.016 0.016 0.011 0.014 0.026
z 1.80 5.08 3.39 21.79 17.4 8.20
p-value 0.036 < 10 4 3  10 4 < 10 4 < 10 4 < 10 4
judgement significant significant significant significant significant significant
p = (p1pos N1 + p2pos N2)=(N1 +N2)
 =
p
p  (1  p)  ((1=N1) + (1=N2))
z = (p1pos   p2pos)=
Table 5.11: The two-sample proportion test results(positive) in overall
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Disease Breast Cancer Breast Cancer Breast Cancer Depression Depression Depression
Treatment 1 Chemo Chemo Radiation Meditation Meditation Meditation
Treatment 2 Radiation Hormonal Hormonal SSRI SNRIa TCA
N1 2476 2476 2154 1454 1454 1454
N2 2154 1486 1486 10996 4131 473
p1neg 26.29% 26.29% 28.50% 35.63% 35.63% 35.63%
p2neg 28.50% 35.13% 35.13% 59.10% 54.42% 55.60%
p 0.273 0.296 0.312 0.564 0.495 0.405
 0.013 0.015 0.016 0.014 0.015 0.026
z -1.68 -5.90 -4.24 -16.96 -12.32 -7.68
p-value 0.05 < 10 4 < 10 4 < 10 4 < 10 4 < 10 4
judgement significant significant significant significant significant significant
p = (p1neg N1 + p2neg N2)=(N1 +N2)
 =
p
p  (1  p)  ((1=N1) + (1=N2))
z = (p1neg   p2neg)=
Table 5.12: The two-sample proportion test results(negative) in overall
From Table 5.11 and 5.12 we observe that, in all the pairs, p1pos is significantly larger than
p2pos, while p1neg is significantly smaller than p2neg, indicating that the number of authors
who preferred Treatment 1 is significantly more than that of Treatment 2, for each case. The
conclusion is consistent with the one we draw from Section 5.2.1 and 5.2.2.
5.2.4 Experiment D: Demographic Analysis
Table 5.13- 5.19 show the attitude of each demographic group for each treatment: chemo, radi-
ation, hormonal for breast cancer; meditation, SSRI, SNRI, TCA for depression, respectively.
Note in these tables, some groups’ statistics is not included (e.g., Age 18  29 for Breast Can-
cer, Age 65+ for Depression) since the sample size is too small.
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Group Age 30-49 Age 50-64 Age 65+ Northeast Midwest South West
# of authors mention-
ing Chemo
700 709 433 317 315 592 399
percentage of positive 45.50% 43.22% 37.5% 39.62% 48.57% 42.13% 47.37%
percentage of negative 24.89% 26.69% 28.61% 33.02% 20.95% 24.87% 24.06%
percentage of neutral 29.61% 30.08% 33.89% 27.36% 30.48% 32.99% 28.57%
Table 5.13: The attitude to Chemo, Breast Cancer
Group Age 30-49 Age 50-64 Age 65+ Northeast Midwest South West
# of authors mention-
ing Radiation
484 706 378 275 313 533 407
percentage of positive 45.96% 34.04% 42.06% 42.39% 40.38% 33.90% 41.91%
percentage of negative 25.46% 30.21% 18.25% 20.65% 25.96% 31.64% 26.47%
percentage of neutral 28.57% 35.74% 39.68% 36.96% 33.65% 34.46% 31.62%
Table 5.14: The attitude to Radiation, Breast Cancer
Group Age 30-49 Age 50-64 Age 65+ Northeast Midwest South West
# of authors mention-
ing Hormonal
408 487 217 216 229 343 260
percentage of positive 42.65% 30.25% 27.78% 30.56% 34.21% 38.60% 35.63%
percentage of negative 30.15% 39.51% 44.44% 38.89% 36.84% 29.82% 31.03%
percentage of neutral 27.20% 30.25% 27.78% 30.56% 28.95% 31.58% 33.34%
Table 5.15: The attitude to Hormonal, Breast Cancer
Group Male Female Age 18-29 Age 30-49 Age 50-64 Northeast Midwest South West
# of authors mention-
ing Meditation
396 781 432 597 156 200 211 297 235
percentage of positive 43.33% 48.23% 44.44% 44.64% 47.44% 47% 41.90% 46.62% 41.52%
percentage of negative 36.97% 32.26% 34.26% 35.91% 28.21% 33% 38.10% 37.84% 33.05%
percentage of neutral 19.70% 19.51% 21.30% 17.45% 24.36% 20% 20% 15.54% 25.42%
Table 5.16: The attitude to Meditation, Depression
Group Male Female Age 18-29 Age 30-49 Age 50-64 Northeast Midwest South West
# of authors mention-
ing SSRI
1862 4216 1957 2967 990 1217 1248 1993 1230
percentage of positive 18.81% 21.66% 18.28% 19.82% 20.20% 21.67% 18.91% 19.08% 20%
percentage of negative 60.63% 58.23% 60.57% 59.61% 58.38% 56.98% 59.45% 59.27% 57.72%
percentage of neutral 20.55% 20.04% 21.14% 20.57% 21.41% 21.35% 21.63% 21.69% 22.28%
Table 5.17: The attitude to SSRI, Depression
Group Male Female Age 18-29 Age 30-49 Age 50-64 Northeast Midwest South West
# of authors mention-
ing SNRI
671 1707 597 1242 538 455 498 793 507
percentage of positive 20.93% 21.79% 19.80% 22.22% 21.19% 21.49% 15.26% 21.72% 24.90%
percentage of negative 57.25% 55.38% 55.70% 56.36% 55.76% 57.02% 58.23% 57.58% 54.56%
percentage of neutral 21.82% 22.84% 22.50% 21.42% 23.05% 21.49% 26.51% 20.71% 20.55%
Table 5.18: The attitude to SNRI, Depression
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Group Male Female Age 18-29 Age 30-49 Age 50-64 Northeast Midwest South West
# of authors mention-
ing TCA
95 180 48 143 91 63 54 74 99
percentage of positive 24.05% 26.67% 25% 27.78% 20% 35.48% 18.52% 21.62% 17.24%
percentage of negative 56.96% 53.33% 58.33% 54.17% 66.67% 51.61% 62.96% 54.05% 65.52%
percentage of neutral 18.99% 20% 16.67% 18.06% 13.33% 12.90% 18.52% 24.32% 17.24%
Table 5.19: The attitude to TCA, Depression
Inner-group experiment
In this section we will compare the preference between two treatments of a particular demo-
graphic group, by using the indirect comparison similar to the one in Section 5.2.3: for each
pair of treatments T1 and T2, given
 p1pos: the percentage of authors having positive opinion on T1
 p2pos: the percentage of authors having positive opinion on T2
 p1neg: the percentage of authors having negative opinion on T1
 p2neg: the percentage of authors having negative opinion on T2
, if more people are positive on T1 meanwhile less people are negative on T1, i.e., p1pos is
significantly larger than p2pos meanwhile p1neg is significantly smaller than p2neg, we can con-
clude that the number of authors who preferred T1 is significantly more than that of T2, vice
versa. While comparing the independent portions, the two-sample proportion test is applied.
Table 5.20 shows the preference of a specific demographic group between two treatments
of breast cancer. Note that given the purpose of demographic analysis is to identify groups that
show different preference among others, to save space, here we only present groups for which
statistical analysis showed different conclusion from the trend of overall population.
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Group Age 30-49 Age 65+ Northeast South
Treatment 1 Chemo Chemo Chemo Radiation
Treatment 2 Radiation Radiation Radiation Hormonal
p1pos 45.49% 37.5% 39.62% 33.90%
p2pos 45.96% 42.06% 42.39% 38.60%
judgement p1pos, p2pos not significant different p1pos < p2pos p1pos < p2pos p1pos < p2pos
p-value 0.88 0.08 0.07 0.04
p1neg 24.89% 28.61% 33.02% 31.64%
p2neg 25.47% 18.25% 20.65% 28.82%
judgement p1neg , p2neg not significant different p1neg > p2neg p1neg > p2neg p1neg > p2neg
p-value 1.15 0.002 3  10 4 0.09
For the space limitation, if the preference of a specific group is the same as the overall population according to the same pair of treatments,
we do not list them in the table
Table 5.20: The preference of inner-group of Breast Cancer
From Table 5.20 we can draw the following conclusion:
 people in age 30 49 group have no different preference between Chemo and Radiation.
 In age 65+ group, the number of people prefer Chemo is smaller than that of Radiation.
 In Northeast area, the number of people prefer Chemo is smaller than that of Radiation.
 In South area, the number of people prefer Radiation is smaller than that of Hormonal.
For Depression, the statistical result shows that, for each pair of treatments, the preference
of every demographic group is consistent with the overall population. It indicates that media-
tion is indeed preferred by people to drug treatment, regardless of their sex, age, or region.
Cross-group experiment
In this section we will compare the attitude on one specific treatment between two demographic
groups. We modify the strategy used in Section 5.2.3 as below:
for two demographic groups G1 and G2 and one treatment T, given
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Treatment T Chemo Radiation Hormonal
Group 1 Northeast Age 50-64 Age 30-49
Group 2 Midwest Age 65+ Age 50-64
p1pos 39.62% 34.04% 42.65%
p2pos 48.57% 42.06% 30.25%
judgement p1pos < p2pos p1pos < p2pos p1pos > p2pos
p-value 0.012 0.005 < 10 4
p1neg 33.02% 30.21% 30.15%
p2neg 20.95% 18.25% 39.51%
judgement p1neg > p2neg p1neg > p2neg p1neg < p2neg
p-value 3  10 4 < 10 4 0.002
Table 5.21: The preference of cross-group for breast cancer
Treatment T Meditation SSRI SNRI TCA
Group 1 Male Midwest Midwest Age 30-49
Group 2 Female South West Age 50-64
p1pos 43.33% 18.97% 15.26% 27.78%
p2pos 48.23% 19.07% 24.90% 20%
judgement p1pos < p2pos p1pos, p2pos not different p1pos < p2pos p1pos > p2pos
p-value 0.05 0.79 < 10 4 0.09
p1neg 36.97% 59.46% 58.23% 54.17%
p2neg 32.26% 59.24% 54.55% 66.67%
judgement p1neg > p2neg p1neg , p2neg not different p1neg > p2neg p1neg < p2neg
p-value 0.05 0.51 0.05 0.03
Table 5.22: The preference of cross-group for depression
 p1pos: the percentage of authors in G1 having positive opinion on T
 p2pos: the percentage of authors in G2 having positive opinion on T
 p1neg: the percentage of authors in G1 having negative opinion on T
 p2neg: the percentage of authors in G2 having negative opinion on T
, if more people in G1 are positive and less people are negative, compared with the G2, i.e.,
p1pos is significantly larger than p2pos as well as p1neg is significantly smaller than p2neg, we
can conclude that Group 1 have a more positive opinion on the particular treatment than Group
2. Again we conduct the two-sample proportion test.
Table 5.21 and 5.22 shows the preference to one specific treatment for breast cancer and
depression respectively between two demographic groups. Since for each treatment there are
multiple choices of the pair of demographic groups, for the space limitation, we only list group
pairs that exhibit interesting results, for each treatment respectively.
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From Table 5.21 and 5.22 we can observe that:
 people in Midwest prefer Chemo significantly more than people in Northeast.
 people in age 65+ prefer Radiation significantly more than people in age 50-64.
 people in age 30-49 prefer Hormonal significantly more than people in age 50-64.
 Women prefer Meditation significantly more than men.
 people in Midwest has no difference in preference to SSRI with people in South.
 people in West prefer SNRI significantly more than people in Midwest.
 people in age 30-49 prefer TCA more than people in age 50-64.
These conclusions could be understand intuitively. e.g. older people are more fragile to
bear Chemo thus they would more prefer to relatively mild therapy such as Radiation. Younger
people are more easy to the relatively novel therapy, such as Hormonal. Also the number of
women who take yoga training are significantly larger than men. When it comes to a treat-
ment of depression, women would show more interest to try meditation. While these are all
reasonable inference, future research is needed to verify these statements.
From our observation we found that part of our conclusions drawn from the demographic
analysis have been validated by real clinical trials. For example, The major global longitudinal
study called the Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) [96] found that
“Allocation to about 6 months of chemo reduces the annual breast cancer death rate by about
38% (SE 5) for women younger than 50 years of age when diagnosed and by about 20% (SE 4)
for those of age 50  69 years when diagnosed”, which indicates that chemo is more effective
to younger group (< 50), compared with older group(> 50). Similarly, Segal et al [97] found
that 8 weeks of mindfulness mediation training was just as good as prolonged antidepressant
treatment (SSRI, SNRI) over 18months. Also considering the lower cost and fewer side effects
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of meditation therapy, it is understandable why patients preferred meditation more, even in each
demographic group.
From the demographic analysis, we can automatically predict the preference comparison
among different groups, which can be used as hypotheses to be tested in clinical research.
77
5.3 Limitations
Our work may have following limitations:
 Preference versus Effectiveness. From the results in Section 5.2, our approach can auto-
matically compare the preference for treatments of any group of patients, however, self
reported preference may not be equal to effectiveness. For example, patient may prefer
a treatment simply because it causes less pain or side effects, while the same treatment
can in fact be less effective in treating the disease. In general, conclusion drawn from
mining online personal health message can only be used as a supportive evidence for
forming hypotheses, but not replace formal clinical trials. In Section 5.2.4, we have
validated part of our conclusions with the results of clinical trials. Further research is
also needed to systematically identify the relation between the patients’ preference s-
tated in personal health message and the actual treatment effectiveness. i.e., validating
the current hypotheses generated from personal messages by comparing with the formal
medical literature or reports.
 Reliability. One advantage of online personal messages is that they are easy to acquire
and utilize. However, compared with clinic notes or medical literature, not all the person-
al messages are reliable. i.e., some of them may submit the messages with questionable
motivation (e.g., commercial purpose) which do not accurately reflect patient experience,
and some users may provide the incorrect profile information. Unreliable personal mes-
sages will affect the quality and validity of our results. In our current experiment, all
the messages are considered having the equal reliability. Such result can be improved
by techniques detecting low quality or dubious posts or personal profile, and weight-
ed message scores (by assigning more weight to authors who provide reliable messages
and profile information) Some data mining researchers have explored the approach of
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truth discovery from web data [98], [99]. We can apply the techniques into the current
experiment to improve the reliability in the future.
 Scalability of the data. MedHelp provides more than 100 sub-forums for patients to com-
municate with each other. However not all the treatments or diseases are fully discussed,
which makes the quality of messages insufficient to explore. (e.g., COPD forum has on-
ly 2000 personal messages, etc). Therefore we should consider aggregating data across
multiple web sources, e.g. the Health and Wellness parts of Yahoo Groups that contain
demographic information about unique individuals, Twitter 4 which has much more per-
sonal messages. Although it seems straightforward to apply the same techniques to other
sources, future research is needed to analyze the preference consistency, information
quality consistency and population bias among different sources.
4http://www.twitter.com
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5.4 Conclusion and Future Work
In this chapter, I introduce our CER hypothesis prediction framework – automatically gener-
ating the hypotheses of patients’ preferences on different treatments of breast cancer and de-
pression, respectively. By utilizing three comparison approaches together with statistical test,
we can successfully draw reliable and consistent conclusions from personal health messages.
Furthermore, from the user profile information, we can also explore the demographic infor-
mation and aggregate patients’ preferences upon it. By applying inner-group and cross-group
analysis, we can detect the differences among demographic groups and answer the question
“which treatment is more effective and favored by whom?”
Based on CER’s definition, the real pragmatic trials are required thus conclusions can not be
made by only analyzing text-based personal messages. In the future, solid hypotheses valida-
tion is necessary by comparing our auto-generated conclusions from personal health messages
with the conclusions drawn from electronic medical record or clinical trials.
In our case study, breast cancer and depression are fully investigated. In the future, more
treatments and diseases will be tested by aggregating data across multiple web sources, such
as Yahoo! Groups with demographic information, as well as Twitter. Thus, an interactive
system can be built for patients to search and compare the effectiveness of treatments via ad-
hoc queries.
80
CHAPTER 6
Conclusion and Summary
The development of Web 2.0 techniques has led to the prosperity of online communities, which
spread to various domains and areas in our daily life. When it comes to the medicine and
healthcare domain, a series of good online services such as Yahoo! Groups, WebMD and
MedHelp, offer patients and physicians a good platform to discuss health problems, e.g., dis-
eases and drugs, diagnoses and treatments, which also provides a large volume of data for
researchers to analyze and explore. However, some nature of the personal messages, e.g., un-
clean, unstructured and isolated from clinical practice, hinders users’ effective digestion of
information in the front end and challenges the data analysis in the back end.
In this thesis, I apply the advanced data mining, information retrieval and natural language
processing techniques to effectively analyze and re-organize the rich source of personal health
messages from online medical communities, in order to satisfy patients’ information need and
support physicians’ clinical practise. Specially, in the first part of the dissertation, I introduce
an SVM-based multi-class classification method which utilizes term-appearance, lexical and
semantic features to effectively classify health messages sampled from our unique dataset of
Yahoo! Health Groups into three categories: News, User Comments and Spam; in the second
part, I depict a comprehensive system with an extensive evaluation framework to organize and
cluster patient outcomes utilizing topic model; in the third part of the dissertation, I address
a novel and promising topic: comparative effectiveness research (CER) hypothesis prediction,
by presenting a study which evaluates patients’ opinions on different treatments by machine
enabled sentiment analysis or human analysts utilizing our MedHelp dataset. By solving these
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three problems, we conclude that personal health messages enrich the information sources
which patients and physicians request the and expand the scope that traditional medical infor-
matics research can reach.
However this thesis can not discuss the full usage of personal health messages. To further
explore such scalable and diverse information, two interesting and promising directions can be
studied deeply:
 Voice-based messages annotation: Currently our work is relied on text-based messages.
However with the popularity of mobile phones, people can choose to express their health-
related experiences as the format of voice messages. If the feature of the voice can be
adequately captured, we can transplanted the text-based techniques onto voice-based
messages. Some researchers have begun to analyze the usage of voice messages in im-
proving health outcomes and processes of care [100, 101].
 Medical validation: In Section 5.2.4, we have validated part of our conclusions with the
results of clinical trials. However it is not enough. Further research is also needed to sys-
tematically identify the relation between the patients’ preference stated in personal health
message and the actual treatment effectiveness. i.e., validating the current hypotheses
generated from personal messages by comparing with the formal medical literature or
reports from clinical trials.
 Medical messages comparison across multiple web sources: the topic of multiple web
sources comparison has been discussed in many research and application areas, such as
web search recommendation [102], bursty event tracking [69], etc. However, in medical
informatics area, this topic has not been addressed although different healthcare-related
web sources exist. More scalable and reliable data can be acquired and aggregated by ful-
ly analyzing the characters of each of the web sources and investigating the correlations
among them.
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Last but not least, the purpose of this dissertation is to draw more and more researchers’
interests to the study of personal health messages in order to offer better service and medical
care to patients, eventually to everyone.
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